Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation
The cytochrome P450 (CYP) epoxygenase enzymes CYP2J and CYP2C catalyze the epoxidation of arachidonic acid to epoxyeicosatrienoic acids (EETs), which are rapidly hydrolyzed to dihydroxyeicosatrienoic acids (DHETs) by soluble epoxide hydrolase (sEH). It is well-established that CYP epoxygenase-derive...
Saved in:
| Published in | Journal of molecular and cellular cardiology Vol. 48; no. 2; pp. 331 - 341 |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | English |
| Published |
England
Elsevier Ltd
01.02.2010
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0022-2828 1095-8584 1095-8584 |
| DOI | 10.1016/j.yjmcc.2009.10.022 |
Cover
| Abstract | The cytochrome P450 (CYP) epoxygenase enzymes CYP2J and CYP2C catalyze the epoxidation of arachidonic acid to epoxyeicosatrienoic acids (EETs), which are rapidly hydrolyzed to dihydroxyeicosatrienoic acids (DHETs) by soluble epoxide hydrolase (sEH). It is well-established that CYP epoxygenase-derived EETs possess potent vasodilatory effects; however, the cellular effects of EETs and their regulation of various inflammatory processes have become increasingly appreciated in recent years, suggesting that the role of this pathway in the cardiovascular system extends beyond the maintenance of vascular tone. In particular, CYP epoxygenase-derived EETs inhibit endothelial activation and leukocyte adhesion via attenuation of nuclear factor-kappaB activation, inhibit hemostasis, protect against myocardial ischemia–reperfusion injury, and promote endothelial cell survival via modulation of multiple cell signaling pathways. Thus, the CYP epoxygenase pathway is an emerging target for pharmacological manipulation to enhance the cardiovascular protective effects of EETs. This review will focus on the role of the CYP epoxygenase pathway in the regulation of cardiovascular inflammation and (1) describe the functional impact of CYP epoxygenase-derived EET biosynthesis and sEH-mediated EET hydrolysis on key inflammatory process in the cardiovascular system, (2) discuss the potential relevance of this pathway to pathogenesis and treatment of cardiovascular disease, and (3) identify areas for future research. |
|---|---|
| AbstractList | The cytochrome P450 (CYP) epoxygenase enzymes CYP2J and CYP2C catalyze the epoxidation of arachidonic acid to epoxyeicosatrienoic acids (EETs), which are rapidly hydrolyzed to dihydroxyeicosatrienoic acids (DHETs) by soluble epoxide hydrolase (sEH). It is well-established that CYP epoxygenase-derived EETs possess potent vasodilatory effects; however, the cellular effects of EETs and their regulation of various inflammatory processes have become increasingly appreciated in recent years, suggesting that the role of this pathway in the cardiovascular system extends beyond the maintenance of vascular tone. In particular, CYP epoxygenase-derived EETs inhibit endothelial activation and leukocyte adhesion via attenuation of nuclear factor-kappaB activation, inhibit hemostasis, protect against myocardial ischemia-reperfusion injury, and promote endothelial cell survival via modulation of multiple cell signaling pathways. Thus, the CYP epoxygenase pathway is an emerging target for pharmacological manipulation to enhance the cardiovascular protective effects of EETs. This review will focus on the role of the CYP epoxygenase pathway in the regulation of cardiovascular inflammation and (1) describe the functional impact of CYP epoxygenase-derived EET biosynthesis and sEH-mediated EET hydrolysis on key inflammatory process in the cardiovascular system, (2) discuss the potential relevance of this pathway to pathogenesis and treatment of cardiovascular disease, and (3) identify areas for future research. Abstract The cytochrome P450 (CYP) epoxygenase enzymes CYP2J and CYP2C catalyze the epoxidation of arachidonic acid to epoxyeicosatrienoic acids (EETs), which are rapidly hydrolyzed to dihydroxyeicosatrienoic acids (DHETs) by soluble epoxide hydrolase (sEH). It is well-established that CYP epoxygenase-derived EETs possess potent vasodilatory effects; however, the cellular effects of EETs and their regulation of various inflammatory processes have become increasingly appreciated in recent years, suggesting that the role of this pathway in the cardiovascular system extends beyond the maintenance of vascular tone. In particular, CYP epoxygenase-derived EETs inhibit endothelial activation and leukocyte adhesion via attenuation of nuclear factor-kappaB activation, inhibit hemostasis, protect against myocardial ischemia–reperfusion injury, and promote endothelial cell survival via modulation of multiple cell signaling pathways. Thus, the CYP epoxygenase pathway is an emerging target for pharmacological manipulation to enhance the cardiovascular protective effects of EETs. This review will focus on the role of the CYP epoxygenase pathway in the regulation of cardiovascular inflammation and (1) describe the functional impact of CYP epoxygenase-derived EET biosynthesis and sEH-mediated EET hydrolysis on key inflammatory process in the cardiovascular system, (2) discuss the potential relevance of this pathway to pathogenesis and treatment of cardiovascular disease, and (3) identify areas for future research. The cytochrome P450 (CYP) epoxygenase enzymes CYP2J and CYP2C catalyze the epoxidation of arachidonic acid to epoxyeicosatrienoic acids (EETs), which are rapidly hydrolyzed to dihydroxyeicosatrienoic acids (DHETs) by soluble epoxide hydrolase (sEH). It is well-established that CYP epoxygenase-derived EETs possess potent vasodilatory effects; however, the cellular effects of EETs and their regulation of various inflammatory processes have become increasingly appreciated in recent years, suggesting that the role of this pathway in the cardiovascular system extends beyond the maintenance of vascular tone. In particular, CYP epoxygenase-derived EETs inhibit endothelial activation and leukocyte adhesion via attenuation of nuclear factor-kappaB activation, inhibit hemostasis, protect against myocardial ischemia-reperfusion injury, and promote endothelial cell survival via modulation of multiple cell signaling pathways. Thus, the CYP epoxygenase pathway is an emerging target for pharmacological manipulation to enhance the cardiovascular protective effects of EETs. This review will focus on the role of the CYP epoxygenase pathway in the regulation of cardiovascular inflammation and (1) describe the functional impact of CYP epoxygenase-derived EET biosynthesis and sEH-mediated EET hydrolysis on key inflammatory process in the cardiovascular system, (2) discuss the potential relevance of this pathway to pathogenesis and treatment of cardiovascular disease, and (3) identify areas for future research.The cytochrome P450 (CYP) epoxygenase enzymes CYP2J and CYP2C catalyze the epoxidation of arachidonic acid to epoxyeicosatrienoic acids (EETs), which are rapidly hydrolyzed to dihydroxyeicosatrienoic acids (DHETs) by soluble epoxide hydrolase (sEH). It is well-established that CYP epoxygenase-derived EETs possess potent vasodilatory effects; however, the cellular effects of EETs and their regulation of various inflammatory processes have become increasingly appreciated in recent years, suggesting that the role of this pathway in the cardiovascular system extends beyond the maintenance of vascular tone. In particular, CYP epoxygenase-derived EETs inhibit endothelial activation and leukocyte adhesion via attenuation of nuclear factor-kappaB activation, inhibit hemostasis, protect against myocardial ischemia-reperfusion injury, and promote endothelial cell survival via modulation of multiple cell signaling pathways. Thus, the CYP epoxygenase pathway is an emerging target for pharmacological manipulation to enhance the cardiovascular protective effects of EETs. This review will focus on the role of the CYP epoxygenase pathway in the regulation of cardiovascular inflammation and (1) describe the functional impact of CYP epoxygenase-derived EET biosynthesis and sEH-mediated EET hydrolysis on key inflammatory process in the cardiovascular system, (2) discuss the potential relevance of this pathway to pathogenesis and treatment of cardiovascular disease, and (3) identify areas for future research. |
| Author | Lee, Craig R. Deng, Yangmei Theken, Katherine N. |
| AuthorAffiliation | b UNC McAllister Heart Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA a Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA |
| AuthorAffiliation_xml | – name: b UNC McAllister Heart Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA – name: a Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA |
| Author_xml | – sequence: 1 givenname: Yangmei surname: Deng fullname: Deng, Yangmei organization: Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA – sequence: 2 givenname: Katherine N. surname: Theken fullname: Theken, Katherine N. organization: Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA – sequence: 3 givenname: Craig R. surname: Lee fullname: Lee, Craig R. email: craig_lee@unc.edu organization: Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/19891972$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFUl1rFDEUDVKx2-ovEGTefOmu-ZjMJIiFsmgrFBTU55DN3NnNmEnWZGZx_r3Z3Vq0oH0KnHs-wj33DJ344AGhlwQvCCbVm24xdb0xC4qxzMgCU_oEzQiWfC64KE_QDGdoTgUVp-gspQ5nYsnYM3RKpJBE1nSGuuU0BLOJoYfic8lxAdvwc1qD1wnSRZGCG1cODqhtoNhMTQwuzy4K7Zti2EARYT06Pdjgi9AWRsfGhp1OJoOxsL51uu8P4-foaatdghd37zn69uH91-XN_PbT9cfl1e3ccIqHef4ZaNMYYG3ZaspXzOi6LEXNKyp11TIDXHMiK6C8akhbi6rWNWa1aEVZc8PO0eXRdzuueshGfojaqW20vY6TCtqqvyfebtQ67BQVhDFeZYPXdwYx_BghDaq3yYBz2kMYk6oZEyWRkmbmqz-j7jN-7zcT5JFgYkgpQquMHQ7byMnWKYLVvkvVqUOXat_lHszFZS17oL23_6_q3VEFecU7C1ElY8EbaGwEM6gm2Ef0lw_0xllvjXbfYYLUhTH63J4iKlGF1Zf9je1PDEuMy6qss8Hbfxs8Gv8LlyDktA |
| CitedBy_id | crossref_primary_10_1007_s11060_012_0841_4 crossref_primary_10_1124_dmd_110_035287 crossref_primary_10_1152_ajpheart_00633_2019 crossref_primary_10_1152_ajplung_00427_2010 crossref_primary_10_1002_bdd_1931 crossref_primary_10_1371_journal_pone_0094092 crossref_primary_10_1096_fj_10_160119 crossref_primary_10_1186_s13020_024_00927_9 crossref_primary_10_1016_j_jnutbio_2020_108484 crossref_primary_10_1007_s10555_011_9315_y crossref_primary_10_1007_s12013_021_00978_x crossref_primary_10_1194_jlr_M053199 crossref_primary_10_3168_jds_2017_13855 crossref_primary_10_1152_ajpcell_00139_2013 crossref_primary_10_1016_j_chroma_2018_05_072 crossref_primary_10_1016_j_prostaglandins_2018_10_003 crossref_primary_10_3390_ijms21041279 crossref_primary_10_3389_fphar_2018_01572 crossref_primary_10_3109_03602532_2012_756011 crossref_primary_10_1194_jlr_M047357 crossref_primary_10_1134_S1990750824600158 crossref_primary_10_1111_jcmm_14796 crossref_primary_10_1152_ajpendo_00370_2011 crossref_primary_10_1016_j_biopha_2020_111165 crossref_primary_10_1080_10641955_2017_1388390 crossref_primary_10_1016_j_prostaglandins_2024_106816 crossref_primary_10_1111_fcp_12342 crossref_primary_10_31083_j_jin2003078 crossref_primary_10_1016_j_prostaglandins_2012_12_001 crossref_primary_10_1152_ajplung_00208_2015 crossref_primary_10_1146_annurev_nutr_071813_105747 crossref_primary_10_1371_journal_pone_0110162 crossref_primary_10_1016_j_fct_2013_11_042 crossref_primary_10_1016_j_prostaglandins_2016_07_002 crossref_primary_10_1146_annurev_pharmtox_011112_140244 crossref_primary_10_1161_CIRCINTERVENTIONS_111_962555 crossref_primary_10_4199_C00035ED1V01Y201106ISP023 crossref_primary_10_1021_acscentsci_3c00052 crossref_primary_10_1124_mol_117_111047 crossref_primary_10_1016_j_plipres_2022_101194 crossref_primary_10_1016_j_tjog_2019_10_004 crossref_primary_10_1016_j_atherosclerosis_2013_01_034 crossref_primary_10_1016_j_bbrc_2019_09_124 crossref_primary_10_1016_j_neulet_2015_03_024 crossref_primary_10_1210_en_2012_2012 crossref_primary_10_3389_fphar_2014_00239 crossref_primary_10_1016_j_chemphyslip_2018_09_004 crossref_primary_10_1186_s12929_015_0202_7 crossref_primary_10_1016_j_cell_2013_05_052 crossref_primary_10_1111_sji_12791 crossref_primary_10_1152_ajplung_00379_2012 crossref_primary_10_1016_j_gene_2016_06_011 crossref_primary_10_1016_j_yjmcc_2016_01_020 crossref_primary_10_1021_jacs_2c12962 crossref_primary_10_1007_s00423_011_0838_z crossref_primary_10_1096_fj_10_171488 crossref_primary_10_1172_JCI129679 crossref_primary_10_3390_jcdd4040021 crossref_primary_10_1016_j_bbrc_2017_06_007 crossref_primary_10_2337_db10_0110 crossref_primary_10_1016_j_addr_2011_03_006 crossref_primary_10_1097_FJC_0b013e318298e460 crossref_primary_10_1016_j_yjmcc_2014_04_003 crossref_primary_10_1161_ATVBAHA_115_305630 crossref_primary_10_1016_j_pharmthera_2014_05_011 crossref_primary_10_1016_j_vph_2022_107086 crossref_primary_10_1128_mBio_01538_16 crossref_primary_10_1038_s41598_023_39737_8 crossref_primary_10_1080_03602532_2022_2162075 crossref_primary_10_1194_jlr_M061697 crossref_primary_10_1371_journal_pone_0011671 crossref_primary_10_3892_etm_2019_7396 crossref_primary_10_1186_s13195_021_00893_6 crossref_primary_10_1007_s10555_010_9264_x crossref_primary_10_1021_acs_jmedchem_2c00817 crossref_primary_10_1186_1744_8069_7_78 crossref_primary_10_1016_j_ijcard_2015_04_097 crossref_primary_10_1186_s12937_023_00862_9 crossref_primary_10_3389_fphar_2014_00242 crossref_primary_10_1016_j_atherosclerosis_2012_03_022 crossref_primary_10_1371_journal_pone_0039165 crossref_primary_10_1152_physrev_00004_2012 crossref_primary_10_1371_journal_pone_0179450 crossref_primary_10_1021_jm500262m crossref_primary_10_1016_j_pain_2012_04_027 crossref_primary_10_1111_j_1549_8719_2012_00202_x crossref_primary_10_2174_1874467215666220413085316 crossref_primary_10_1007_s12013_020_00928_z crossref_primary_10_1080_03602532_2018_1439502 crossref_primary_10_3736_jintegrmed2013047 crossref_primary_10_1164_rccm_201403_0544OC crossref_primary_10_1016_j_prostaglandins_2021_106595 crossref_primary_10_1042_CS20200310 crossref_primary_10_1124_dmd_119_086611 crossref_primary_10_1152_ajprenal_00129_2012 crossref_primary_10_1016_j_bbadis_2017_02_004 crossref_primary_10_3390_ijms22147680 crossref_primary_10_1016_j_bcp_2021_114850 crossref_primary_10_1016_j_prostaglandins_2018_07_005 crossref_primary_10_1155_2019_8687120 crossref_primary_10_1039_C8FO01076E crossref_primary_10_18632_oncotarget_17331 crossref_primary_10_1016_j_cca_2023_117616 crossref_primary_10_1152_ajplung_00394_2016 crossref_primary_10_1016_j_neures_2016_05_002 crossref_primary_10_1152_ajpheart_00706_2023 crossref_primary_10_1016_j_prostaglandins_2012_09_003 crossref_primary_10_3390_molecules30071445 crossref_primary_10_1186_s12964_020_0523_3 crossref_primary_10_1016_j_yjmcc_2014_05_016 crossref_primary_10_1586_erc_12_1 crossref_primary_10_1124_jpet_110_167544 crossref_primary_10_1152_ajpheart_00920_2013 crossref_primary_10_1016_j_bbalip_2014_07_020 crossref_primary_10_1016_j_smim_2013_08_006 crossref_primary_10_1038_s41467_020_19335_2 crossref_primary_10_1089_ars_2017_7056 crossref_primary_10_1152_ajpheart_00568_2015 crossref_primary_10_1016_j_prostaglandins_2019_106400 crossref_primary_10_1517_17425255_2014_872240 crossref_primary_10_1007_s10517_024_06153_5 crossref_primary_10_1155_2022_1079803 crossref_primary_10_1021_acsbiomedchemau_4c00100 crossref_primary_10_1016_j_vph_2019_01_001 crossref_primary_10_1517_17425255_2014_859675 crossref_primary_10_3390_metabo12040342 crossref_primary_10_1007_s10753_016_0495_z crossref_primary_10_1016_j_pharmthera_2017_05_004 crossref_primary_10_1016_j_prostaglandins_2018_03_004 crossref_primary_10_3109_03602532_2013_837916 crossref_primary_10_1016_j_pharmthera_2017_05_005 crossref_primary_10_1161_HYPERTENSIONAHA_117_10644 crossref_primary_10_1021_acs_analchem_1c02058 |
| Cites_doi | 10.1152/ajpheart.00979.2007 10.1038/nature01323 10.1073/pnas.0809765105 10.1016/j.bmcl.2003.08.060 10.1161/01.HYP.0000090123.55365.BA 10.3109/03602539709037591 10.1016/j.prostaglandins.2006.05.017 10.1152/ajpheart.00953.2005 10.1073/pnas.0703229104 10.2217/14622416.8.10.1369 10.1161/ATVBAHA.108.171298 10.1152/ajpheart.01118.2001 10.1152/ajplung.00273.2003 10.1016/S0024-3205(02)01533-3 10.1074/jbc.M305385200 10.1152/ajpregu.00018.2004 10.1161/01.RES.0000018162.87285.F8 10.1007/s11010-007-9611-6 10.1161/01.RES.0000139436.89654.c8 10.1016/S0002-9440(10)63142-2 10.1161/01.CIR.94.12.3341 10.1124/jpet.103.052787 10.1006/taap.2001.9131 10.1016/S0021-9258(18)66872-3 10.1097/01.CCM.0000124877.86743.37 10.1161/01.CIR.0000143832.91812.60 10.1161/ATVBAHA.107.161190 10.1074/jbc.274.34.23679 10.1002/jcp.21356 10.1161/01.ATV.0000116219.09040.8c 10.1016/0005-2760(84)90256-X 10.1074/jbc.271.7.3460 10.1016/j.atherosclerosis.2006.02.021 10.1074/jbc.M008106200 10.1016/j.prostaglandins.2006.05.003 10.1124/jpet.109.152017 10.1016/S0022-3565(24)39260-2 10.1074/jbc.271.52.33157 10.1074/jbc.M501730200 10.1124/dmd.32.4.367 10.1016/j.prostaglandins.2006.05.025 10.1097/00008571-200110000-00006 10.1074/jbc.M503945200 10.1161/hy0202.103788 10.1073/pnas.0503279102 10.1016/S0090-9556(25)07366-0 10.1124/jpet.105.085605 10.1152/ajpcell.00271.2002 10.1158/0008-5472.CAN-06-3643 10.1074/jbc.M201575200 10.1073/pnas.0409591102 10.1152/ajplung.00039.2003 10.1152/ajprenal.00098.2009 10.1161/01.CIR.0000105763.51286.7F 10.1152/physiolgenomics.00310.2004 10.1074/jbc.M203436200 10.1016/0006-291X(90)91741-A 10.1152/ajpcell.00230.2008 10.1161/01.ATV.0000151648.58516.eb 10.1093/hmg/ddi315 10.1074/jbc.R100030200 10.1073/pnas.0609158103 10.1097/FPC.0b013e32809913ea 10.1161/01.ATV.0000217611.81085.c5 10.1126/science.2492116 10.1124/jpet.105.083477 10.1152/ajpheart.00082.2006 10.1161/01.HYP.0000029240.44253.5E 10.1161/01.RES.0000017727.35930.33 10.1016/j.atherosclerosis.2006.11.001 10.1016/S0021-9258(18)31383-8 10.1038/ng.129 10.1096/fj.02-0640fje 10.1161/01.CIR.101.3.235 10.1177/002215540405200403 10.1161/01.RES.88.1.44 10.1016/j.yjmcc.2008.09.711 10.1124/dmd.106.013839 10.1152/ajprenal.00092.2003 10.1152/ajpheart.00927.2005 10.1161/01.RES.87.11.992 10.1007/s004240100565 10.1074/jbc.M110806200 10.1152/ajpheart.00071.2006 10.1161/01.HYP.0000047877.36743.FA 10.1073/pnas.0308185100 10.1016/S0026-895X(25)13247-1 10.1160/TH05-02-0092 10.1097/00008571-200312000-00002 10.1073/pnas.0508081102 10.1016/S0022-3565(24)35029-3 10.1161/CIRCRESAHA.107.151720 10.1074/jbc.M011761200 10.1152/ajpheart.00427.2005 10.1016/j.yjmcc.2009.08.017 10.1242/jcs.02674 10.1161/STROKEAHA.107.508325 10.1126/science.285.5431.1276 10.1161/01.HYP.0000198545.01860.90 10.1016/j.bbrc.2005.02.103 10.1124/jpet.303.2.768 10.1177/15353702-0322807-03 10.1161/01.ATV.0000160340.72641.87 10.1124/mol.60.2.310 10.1016/j.prostaglandins.2006.07.001 10.1038/46816 10.1161/01.CIR.0000139850.08365.EC 10.1161/hy0202.103293 10.1124/dmd.107.018747 10.1016/j.yjmcc.2009.01.009 10.1097/01.fjc.0000189600.74157.6d 10.1038/nm0597-562 10.1016/j.plipres.2005.12.002 10.1073/pnas.261710799 10.1126/science.1091172 10.1161/ATVBAHA.109.186064 10.1124/mol.64.2.482 10.1172/JCI118334 10.1161/01.RES.0000237390.92932.37 10.1152/ajpheart.00428.2008 10.1152/ajpheart.00783.2006 10.1161/01.RES.78.3.415 10.1165/rcmb.2007-0232OC 10.1074/jbc.M100439200 10.1093/cvr/cvp134 10.1097/FJC.0b013e318185fa3c 10.1016/j.yjmcc.2009.02.028 10.1073/pnas.0605908103 10.1006/abbi.1993.1016 10.1113/expphysiol.2007.038612 10.1152/physrev.00021.2001 10.1093/hmg/ddl085 10.1161/01.CIR.0000109487.46725.02 10.1074/jbc.M608057200 10.1016/S0163-7827(03)00049-3 10.1016/j.yjmcc.2006.11.020 10.1182/blood-2007-11-126680 10.2741/1486 |
| ContentType | Journal Article |
| Copyright | 2009 Elsevier Ltd Elsevier Ltd Copyright 2009 Elsevier Ltd. All rights reserved. 2009 Elsevier Ltd. All rights reserved 2009 |
| Copyright_xml | – notice: 2009 Elsevier Ltd – notice: Elsevier Ltd – notice: Copyright 2009 Elsevier Ltd. All rights reserved. – notice: 2009 Elsevier Ltd. All rights reserved 2009 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
| DOI | 10.1016/j.yjmcc.2009.10.022 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1095-8584 |
| EndPage | 341 |
| ExternalDocumentID | PMC2813356 19891972 10_1016_j_yjmcc_2009_10_022 S0022282809004647 1_s2_0_S0022282809004647 |
| Genre | Review Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: American Heart Association-American Stroke Association grantid: 0765247U – fundername: NIGMS NIH HHS grantid: R01 GM088199 – fundername: NIGMS NIH HHS grantid: R01GM088199 |
| GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29L 3O- 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABFRF ABGSF ABJNI ABLJU ABMAC ABMZM ABUDA ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACLOT ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADFGL ADMUD ADNMO ADUVX AEBSH AEFWE AEHWI AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGHFR AGQPQ AGRDE AGUBO AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG COF CS3 DM4 DU5 EBS EFBJH EFKBS EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HEB HLW HMK HMO HVGLF HZ~ IHE J1W K-O KOM L7B LX2 M29 M41 MO0 N9A O-L O9- OAUVE OA~ OL0 OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SBG SCC SDF SDG SDP SEL SES SEW SPCBC SSH SSU SSZ T5K WUQ X7M XPP Z5R ZGI ZMT ZU3 ~G- ~HD AACTN AFCTW AFKWA AJOXV AMFUW RIG AAIAV ABLVK ABYKQ AHPSJ AJBFU DOVZS LCYCR AAYXX CITATION AGCQF AGRNS CGR CUY CVF ECM EIF NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c520t-891eacdce3f4fa25b3ca744875629a6f3ce5a5196e256d1f7867a70378f8475c3 |
| IEDL.DBID | AIKHN |
| ISSN | 0022-2828 1095-8584 |
| IngestDate | Tue Sep 30 16:51:29 EDT 2025 Sun Sep 28 00:07:57 EDT 2025 Mon Jul 21 05:59:13 EDT 2025 Wed Oct 01 05:15:25 EDT 2025 Thu Apr 24 22:58:40 EDT 2025 Fri Feb 23 02:33:02 EST 2024 Sun Feb 23 10:19:52 EST 2025 Tue Oct 14 19:29:02 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | CYP2C EET Cytochrome P450 Soluble epoxide hydrolase Endothelial Inflammation CYP2J Epoxyeicosatrienoic acid Epoxygenase |
| Language | English |
| License | Copyright 2009 Elsevier Ltd. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c520t-891eacdce3f4fa25b3ca744875629a6f3ce5a5196e256d1f7867a70378f8475c3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| PMID | 19891972 |
| PQID | 733841992 |
| PQPubID | 23479 |
| PageCount | 11 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_2813356 proquest_miscellaneous_733841992 pubmed_primary_19891972 crossref_citationtrail_10_1016_j_yjmcc_2009_10_022 crossref_primary_10_1016_j_yjmcc_2009_10_022 elsevier_sciencedirect_doi_10_1016_j_yjmcc_2009_10_022 elsevier_clinicalkeyesjournals_1_s2_0_S0022282809004647 elsevier_clinicalkey_doi_10_1016_j_yjmcc_2009_10_022 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2010-02-01 |
| PublicationDateYYYYMMDD | 2010-02-01 |
| PublicationDate_xml | – month: 02 year: 2010 text: 2010-02-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Journal of molecular and cellular cardiology |
| PublicationTitleAlternate | J Mol Cell Cardiol |
| PublicationYear | 2010 |
| Publisher | Elsevier Ltd |
| Publisher_xml | – name: Elsevier Ltd |
| References | Sacerdoti, Colombrita, Di Pascoli, Schwartzman, Bolognesi, Falck (bib50) 2007; 82 Medhora, Dhanasekaran, Gruenloh, Dunn, Gabrilovich, Falck (bib99) 2007; 82 Dorrance, Rupp, Pollock, Newman, Hammock, Imig (bib81) 2005; 46 Zhang, Cao, Rao (bib91) 2006; 281 Barbosa-Sicard, Markovic, Honeck, Christ, Muller, Schunck (bib110) 2005; 329 Enayetallah, French, Thibodeau, Grant (bib9) 2004; 52 Wang, Wei, Xiao, Hui, Card, Carey (bib90) 2005; 314 Chen, Li, Liao, Wu, Liu, Ma (bib98) 2009; 329 Zhang, Otsuka, Sugo, Ardeshiri, Alhadid, Iliff (bib82) 2008; 39 Falck, Reddy, Reddy, Bondlela, Krishna, Ji (bib28) 2003; 13 Medhora, Daniels, Mundey, Fisslthaler, Busse, Jacobs (bib86) 2003; 284 Pratt, Rosolowsky, Campbell (bib31) 2002; 70 Lee, North, Bray, Couper, Heiss, Zeldin (bib136) 2007; 17 Pasceri, Wu, Willerson, Yeh (bib39) 2000; 101 Cowart, Wei, Hsu, Johnson, Krishna, Falck (bib41) 2002; 277 Zhao, Pollock, Inscho, Zeldin, Imig (bib122) 2003; 41 Liu, Zhang, Schmelzer, Lee, Fang, Zhu (bib29) 2005; 102 Riddick, Lee, Bhathena, Timsit, Cheng, Morgan (bib130) 2004; 32 Chaudhary, Batchu, Das, Suresh, Falck, Graves (bib80) 2009; 83 Sun, Sui, Bradbury, Zeldin, Conte, Liao (bib101) 2002; 90 Yu, Xu, Huse, Morisseau, Draper, Newman (bib18) 2000; 87 Theken, Lee (bib131) 2007; 8 Potente, Michaelis, Fisslthaler, Busse, Fleming (bib84) 2002; 277 Node, Huo, Ruan, Yang, Spiecker, Ley (bib11) 1999; 285 Rendic, Di Carlo (bib5) 1997; 29 Fleming (bib20) 2007; 82 Feletou, Vanhoutte (bib14) 2006; 26 Michaelis, Fisslthaler, Medhora, Harder, Fleming, Busse (bib87) 2003; 17 Liu, Zhu, Rannou, Lee, Formentin, Zeng (bib45) 2004; 110 Fang, Moore, Stoll, Rich, Kaduce, Weintraub (bib59) 1998; 275 Sacerdoti, Escalante, Abraham, McGiff, Levere, Schwartzman (bib48) 1989; 243 Dhanasekaran, Al-Saghir, Lopez, Zhu, Gutterman, Jacobs (bib96) 2006; 291 Muldowney, Painter, Sanders-Bush, Brown, Vaughan (bib66) 2007; 97 Monti, Fischer, Paskas, Heinig, Schulz, Gosele (bib19) 2008; 40 Barclay, Peters, Sewer, Ferrari, Gonzalez, Morgan (bib115) 1999; 290 Morgan, Goralski, Piquette-Miller, Renton, Robertson, Chaluvadi (bib129) 2008; 36 Gross, Hsu, Falck, Nithipatikom (bib78) 2007; 42 Dhanasekaran, Gruenloh, Buonaccorsi, Zhang, Gross, Falck (bib71) 2008; 294 Pozzi, Macias-Perez, Abair, Wei, Su, Zent (bib89) 2005; 280 Seubert, Zeldin, Nithipatikom, Gross (bib69) 2007; 82 Abraham, Jiang, Yang, Zand, Laniado-Schwartzman, Marji (bib51) 2000; 293 Liu, Li, Chao, Wu, Lin, Tsai (bib133) 2007; 195 Smith, Pinkerton, Watanabe, Pedersen, Ma, Hammock (bib35) 2005; 102 Fornage, Boerwinkle, Doris, Jacobs, Liu, Wong (bib138) 2004; 109 Granville, Tashakkor, Takeuchi, Gustafsson, Huang, Sayen (bib105) 2004; 101 Webler, Michaelis, Popp, Barbosa-Sicard, Murugan, Falck (bib93) 2008; 295 Sasaki, Ostanin, Elrod, Oshima, Jordan, Itoh (bib104) 2003; 284 Wang, Verna, Chen, Chen, Li, Forman (bib40) 2002; 277 Fornage, Lee, Doris, Bray, Heiss, Zeldin (bib139) 2005; 14 Nithipatikom, Moore, Isbell, Falck, Gross (bib77) 2006; 291 Ogungbade, Akinsanmi, Jiang, Oyekan (bib119) 2003; 285 Bauersachs, Popp, Hecker, Sauer, Fleming, Busse (bib53) 1996; 94 Luria, Weldon, Kabcenell, Ingraham, Matera, Jiang (bib23) 2007; 282 Fisslthaler, Popp, Kiss, Potente, Harder, Fleming (bib13) 1999; 401 Lee, North, Bray, Fornage, Seubert, Newman (bib107) 2006; 15 Dai, Zeldin, Blaisdell, Chanas, Coulter, Ghanayem (bib134) 2001; 11 Schmelzer, Kubala, Newman, Kim, Eiserich, Hammock (bib22) 2005; 102 Jiang, Ning, Chen, Ma, Liu, Yang (bib94) 2007; 67 Fang, Kaduce, Weintraub, Harmon, Teesch, Morisseau (bib7) 2001; 276 Node, Ruan, Dai, Yang, Graham, Zeldin (bib65) 2001; 276 Moshal, Zeldin, Sithu, Sen, Tyagi, Kumar (bib30) 2008; 215 Motoki, Merkel, Packwood, Cao, Liu, Iliff (bib76) 2008; 295 Oliw (bib62) 1984; 793 Feige, Gelman, Michalik, Desvergne, Wahli (bib36) 2006; 45 Xu, Li, He, Timofeyev, Lu, Tsai (bib34) 2006; 103 Plutzky (bib37) 2003; 302 Ng, Huang, Reddy, Falck, Lin, Kroetz (bib44) 2007; 35 Inceoglu, Jinks, Ulu, Hegedus, Georgi, Schmelzer (bib61) 2008; 105 Sacerdoti, Bolognesi, Di Pascoli, Gatta, McGiff, Schwartzman (bib49) 2006; 291 Fichtlscherer, Dimmeler, Breuer, Busse, Zeiher, Fleming (bib106) 2004; 109 Campbell, Gebremedhin, Pratt, Harder (bib12) 1996; 78 Imig, Zhao, Capdevila, Morisseau, Hammock (bib17) 2002; 39 Seubert, Yang, Bradbury, Graves, Degraff, Gabel (bib73) 2004; 95 Zhang, Vincelette, Cheng, Mehra, Chen, Anandan (bib103) 2009; 29 Gauthier, Deeter, Krishna, Reddy, Bondlela, Falck (bib21) 2002; 90 Ulu, Davis, Tsai, Kim, Morisseau, Inceoglu (bib102) 2008; 52 Wink, Osawa, Darbyshire, Jones, Eshenaur, Nims (bib52) 1993; 300 Sinal, Miyata, Tohkin, Nagata, Bend, Gonzalez (bib15) 2000; 275 Cui, Wu, Zhou, Simms, Wang (bib116) 2004; 32 Bodiga, Zhang, Jacobs, Larsen, Tampo, Manthati (bib72) 2009; 46 Manhiani, Quigley, Knight, Tasoobshirazi, Moore, Brands (bib16) 2009; 297 Wang, Lin, Jiang, Wang, Lu, Bradbury (bib54) 2003; 307 Ye, Zhang, Oltman, Dellsperger, Lee, VanRollins (bib111) 2002; 303 Maresh, Xu, Jiang, Gairola, Shohet (bib127) 2005; 21 Moghaddam, Grant, Cheek, Greene, Williamson, Hammock (bib108) 1997; 3 Pritchard, Tota, Stemerman, Wong (bib26) 1990; 167 Michaelis, Fisslthaler, Barbosa-Sicard, Falck, Fleming, Busse (bib88) 2005; 118 Schmelzer, Inceoglu, Kubala, Kim, Jinks, Eiserich (bib60) 2006; 103 Larsen, Miura, Hatoum, Campbell, Hammock, Zeldin (bib10) 2006; 290 Zhao, Dey, Romanko, Stepp, Wang, Zhou (bib125) 2005; 288 Michaelis, Falck, Schmidt, Busse, Fleming (bib64) 2005; 25 Orozco, Kapturczak, Barajas, Wang, Weinstein, Wong (bib46) 2007; 100 Wang, Smith, Zhou, Chang, Lin, Zhao (bib126) 2003; 42 Wu, Moomaw, Tomer, Falck, Zeldin (bib6) 1996; 271 Fang, Hu, Xu, Snyder, Harmon, Yao (bib43) 2006; 290 Brash (bib1) 1999; 274 Wray, Bishop-Bailey (bib38) 2008; 93 Sewer, Koop, Morgan (bib114) 1996; 24 Fleming, Michaelis, Bredenkotter, Fisslthaler, Dehghani, Brandes (bib27) 2001; 88 Roman (bib3) 2002; 82 Przybyla-Zawislak, Srivastava, Vazquez-Matias, Mohrenweiser, Maxwell, Hammock (bib137) 2003; 64 Cheranov, Karpurapu, Wang, Zhang, Venema, Rao (bib95) 2008; 111 Yang, Graham, Dikalov, Mason, Falck, Liao (bib70) 2001; 60 Yaghi, Bend, Webb, Zeldin, Weicker, Mehta (bib118) 2004; 286 Spiecker, Darius, Hankeln, Soufi, Sattler, Schaefer (bib132) 2004; 110 Ai, Fu, Guo, Tanaka, Wang, Tang (bib120) 2007; 104 Yasar, Bennet, Eliasson, Lundgren, Wiman, De Faire (bib135) 2003; 13 Yaghi, Bradbury, Zeldin, Mehta, Bend, McCormack (bib117) 2003; 285 Yang, Lin, Chen, Lee, Seubert, Wang (bib97) 2007; 293 Seubert, Sinal, Graves, DeGraff, Bradbury, Lee (bib24) 2006; 99 Morin, Sirois, Echave, Gomes, Rousseau (bib33) 2008; 38 Potente, Fisslthaler, Busse, Fleming (bib85) 2003; 278 Davis, Thompson, Howard, Morisseau, Hammock, Weiss (bib100) 2002; 99 de Winther, Kanters, Kraal, Hofker (bib32) 2005; 25 Kozak, Fraifeld (bib58) 2004; 9 Smith, Garavito, DeWitt (bib2) 1996; 271 Zeldin (bib4) 2001; 276 Morita, Kourembanas (bib47) 1995; 96 Krotz, Riexinger, Buerkle, Nithipatikom, Gloe, Sohn (bib68) 2004; 24 Carroll, Balazy, Margiotta, Falck, McGiff (bib63) 1993; 268 Wei, Doris, Pollizotto, Boerwinkle, Jacobs, Siscovick (bib140) 2007; 190 Fleming, Fisslthaler, Michaelis, Kiss, Popp, Busse (bib83) 2001; 442 Spector, Fang, Snyder, Weintraub (bib8) 2004; 43 Slim, Hammock, Toborek, Robertson, Newman, Morisseau (bib109) 2001; 171 Fitzpatrick, Ennis, Baze, Wynalda, McGee, Liggett (bib67) 1986; 261 Libby (bib25) 2002; 420 Kozak, Aronoff, Boutaud, Kozak (bib57) 2003; 228 Lauterbach, Barbosa-Sicard, Wang, Honeck, Kargel, Theuer (bib112) 2002; 39 Morgan (bib128) 2001; 29 Elmarakby, Quigley, Pollock, Imig (bib121) 2006; 47 Fang, Hu, Watanabe, Weintraub, Snyder, Yao (bib42) 2005; 314 Kaergel, Muller, Honeck, Theuer, Shagdarsuren, Mullally (bib123) 2002; 40 Webler, Popp, Korff, Michaelis, Urbich, Busse (bib92) 2008; 28 Li, Liu, Timofeyev, Qiu, Hwang, Tuteja (bib79) 2009 Katragadda, Batchu, Cho, Chaudhary, Falck, Seubert (bib75) 2009; 46 Hercule, Schunck, Gross, Seringer, Leung, Weldon (bib55) 2009; 29 Abdel-Razzak, Loyer, Fautrel, Gautier, Corcos, Turlin (bib113) 1993; 44 Zhang, Cui, Geng, Zeng, Tang (bib56) 2008; 308 Batchu, Law, Brocks, Falck, Seubert (bib74) 2009; 46 Muller, Theuer, Shagdarsuren, Kaergel, Honeck, Park (bib124) 2004; 164 Michaelis (10.1016/j.yjmcc.2009.10.022_bib64) 2005; 25 Yu (10.1016/j.yjmcc.2009.10.022_bib18) 2000; 87 Roman (10.1016/j.yjmcc.2009.10.022_bib3) 2002; 82 Bodiga (10.1016/j.yjmcc.2009.10.022_bib72) 2009; 46 Xu (10.1016/j.yjmcc.2009.10.022_bib34) 2006; 103 Fisslthaler (10.1016/j.yjmcc.2009.10.022_bib13) 1999; 401 Sacerdoti (10.1016/j.yjmcc.2009.10.022_bib48) 1989; 243 Wu (10.1016/j.yjmcc.2009.10.022_bib6) 1996; 271 Fleming (10.1016/j.yjmcc.2009.10.022_bib20) 2007; 82 Kozak (10.1016/j.yjmcc.2009.10.022_bib58) 2004; 9 Moghaddam (10.1016/j.yjmcc.2009.10.022_bib108) 1997; 3 Abraham (10.1016/j.yjmcc.2009.10.022_bib51) 2000; 293 Riddick (10.1016/j.yjmcc.2009.10.022_bib130) 2004; 32 Nithipatikom (10.1016/j.yjmcc.2009.10.022_bib77) 2006; 291 Dorrance (10.1016/j.yjmcc.2009.10.022_bib81) 2005; 46 Zhang (10.1016/j.yjmcc.2009.10.022_bib103) 2009; 29 Oliw (10.1016/j.yjmcc.2009.10.022_bib62) 1984; 793 Seubert (10.1016/j.yjmcc.2009.10.022_bib69) 2007; 82 Motoki (10.1016/j.yjmcc.2009.10.022_bib76) 2008; 295 Liu (10.1016/j.yjmcc.2009.10.022_bib133) 2007; 195 Seubert (10.1016/j.yjmcc.2009.10.022_bib73) 2004; 95 Li (10.1016/j.yjmcc.2009.10.022_bib79) 2009 Lee (10.1016/j.yjmcc.2009.10.022_bib107) 2006; 15 Elmarakby (10.1016/j.yjmcc.2009.10.022_bib121) 2006; 47 Theken (10.1016/j.yjmcc.2009.10.022_bib131) 2007; 8 Bauersachs (10.1016/j.yjmcc.2009.10.022_bib53) 1996; 94 Potente (10.1016/j.yjmcc.2009.10.022_bib84) 2002; 277 Michaelis (10.1016/j.yjmcc.2009.10.022_bib87) 2003; 17 Wang (10.1016/j.yjmcc.2009.10.022_bib90) 2005; 314 Batchu (10.1016/j.yjmcc.2009.10.022_bib74) 2009; 46 Brash (10.1016/j.yjmcc.2009.10.022_bib1) 1999; 274 Sasaki (10.1016/j.yjmcc.2009.10.022_bib104) 2003; 284 Zhao (10.1016/j.yjmcc.2009.10.022_bib122) 2003; 41 Webler (10.1016/j.yjmcc.2009.10.022_bib93) 2008; 295 Yang (10.1016/j.yjmcc.2009.10.022_bib70) 2001; 60 Przybyla-Zawislak (10.1016/j.yjmcc.2009.10.022_bib137) 2003; 64 Liu (10.1016/j.yjmcc.2009.10.022_bib29) 2005; 102 Kozak (10.1016/j.yjmcc.2009.10.022_bib57) 2003; 228 de Winther (10.1016/j.yjmcc.2009.10.022_bib32) 2005; 25 Wang (10.1016/j.yjmcc.2009.10.022_bib54) 2003; 307 Kaergel (10.1016/j.yjmcc.2009.10.022_bib123) 2002; 40 Falck (10.1016/j.yjmcc.2009.10.022_bib28) 2003; 13 Fitzpatrick (10.1016/j.yjmcc.2009.10.022_bib67) 1986; 261 Barclay (10.1016/j.yjmcc.2009.10.022_bib115) 1999; 290 Fang (10.1016/j.yjmcc.2009.10.022_bib43) 2006; 290 Node (10.1016/j.yjmcc.2009.10.022_bib65) 2001; 276 Yaghi (10.1016/j.yjmcc.2009.10.022_bib117) 2003; 285 Sun (10.1016/j.yjmcc.2009.10.022_bib101) 2002; 90 Maresh (10.1016/j.yjmcc.2009.10.022_bib127) 2005; 21 Dhanasekaran (10.1016/j.yjmcc.2009.10.022_bib96) 2006; 291 Pozzi (10.1016/j.yjmcc.2009.10.022_bib89) 2005; 280 Cheranov (10.1016/j.yjmcc.2009.10.022_bib95) 2008; 111 Enayetallah (10.1016/j.yjmcc.2009.10.022_bib9) 2004; 52 Morgan (10.1016/j.yjmcc.2009.10.022_bib128) 2001; 29 Zhang (10.1016/j.yjmcc.2009.10.022_bib56) 2008; 308 Imig (10.1016/j.yjmcc.2009.10.022_bib17) 2002; 39 Orozco (10.1016/j.yjmcc.2009.10.022_bib46) 2007; 100 Wei (10.1016/j.yjmcc.2009.10.022_bib140) 2007; 190 Fichtlscherer (10.1016/j.yjmcc.2009.10.022_bib106) 2004; 109 Fleming (10.1016/j.yjmcc.2009.10.022_bib27) 2001; 88 Yasar (10.1016/j.yjmcc.2009.10.022_bib135) 2003; 13 Chen (10.1016/j.yjmcc.2009.10.022_bib98) 2009; 329 Schmelzer (10.1016/j.yjmcc.2009.10.022_bib60) 2006; 103 Cowart (10.1016/j.yjmcc.2009.10.022_bib41) 2002; 277 Cui (10.1016/j.yjmcc.2009.10.022_bib116) 2004; 32 Abdel-Razzak (10.1016/j.yjmcc.2009.10.022_bib113) 1993; 44 Chaudhary (10.1016/j.yjmcc.2009.10.022_bib80) 2009; 83 Potente (10.1016/j.yjmcc.2009.10.022_bib85) 2003; 278 Morita (10.1016/j.yjmcc.2009.10.022_bib47) 1995; 96 Morin (10.1016/j.yjmcc.2009.10.022_bib33) 2008; 38 Wink (10.1016/j.yjmcc.2009.10.022_bib52) 1993; 300 Muldowney (10.1016/j.yjmcc.2009.10.022_bib66) 2007; 97 Manhiani (10.1016/j.yjmcc.2009.10.022_bib16) 2009; 297 Spiecker (10.1016/j.yjmcc.2009.10.022_bib132) 2004; 110 Krotz (10.1016/j.yjmcc.2009.10.022_bib68) 2004; 24 Wray (10.1016/j.yjmcc.2009.10.022_bib38) 2008; 93 Feletou (10.1016/j.yjmcc.2009.10.022_bib14) 2006; 26 Fleming (10.1016/j.yjmcc.2009.10.022_bib83) 2001; 442 Ulu (10.1016/j.yjmcc.2009.10.022_bib102) 2008; 52 Hercule (10.1016/j.yjmcc.2009.10.022_bib55) 2009; 29 Medhora (10.1016/j.yjmcc.2009.10.022_bib86) 2003; 284 Granville (10.1016/j.yjmcc.2009.10.022_bib105) 2004; 101 Yang (10.1016/j.yjmcc.2009.10.022_bib97) 2007; 293 Fang (10.1016/j.yjmcc.2009.10.022_bib59) 1998; 275 Barbosa-Sicard (10.1016/j.yjmcc.2009.10.022_bib110) 2005; 329 Carroll (10.1016/j.yjmcc.2009.10.022_bib63) 1993; 268 Dai (10.1016/j.yjmcc.2009.10.022_bib134) 2001; 11 Gauthier (10.1016/j.yjmcc.2009.10.022_bib21) 2002; 90 Muller (10.1016/j.yjmcc.2009.10.022_bib124) 2004; 164 Sinal (10.1016/j.yjmcc.2009.10.022_bib15) 2000; 275 Zhang (10.1016/j.yjmcc.2009.10.022_bib91) 2006; 281 Jiang (10.1016/j.yjmcc.2009.10.022_bib94) 2007; 67 Zhao (10.1016/j.yjmcc.2009.10.022_bib125) 2005; 288 Morgan (10.1016/j.yjmcc.2009.10.022_bib129) 2008; 36 Luria (10.1016/j.yjmcc.2009.10.022_bib23) 2007; 282 Schmelzer (10.1016/j.yjmcc.2009.10.022_bib22) 2005; 102 Dhanasekaran (10.1016/j.yjmcc.2009.10.022_bib71) 2008; 294 Ai (10.1016/j.yjmcc.2009.10.022_bib120) 2007; 104 Pratt (10.1016/j.yjmcc.2009.10.022_bib31) 2002; 70 Sewer (10.1016/j.yjmcc.2009.10.022_bib114) 1996; 24 Lauterbach (10.1016/j.yjmcc.2009.10.022_bib112) 2002; 39 Seubert (10.1016/j.yjmcc.2009.10.022_bib24) 2006; 99 Campbell (10.1016/j.yjmcc.2009.10.022_bib12) 1996; 78 Plutzky (10.1016/j.yjmcc.2009.10.022_bib37) 2003; 302 Slim (10.1016/j.yjmcc.2009.10.022_bib109) 2001; 171 Smith (10.1016/j.yjmcc.2009.10.022_bib35) 2005; 102 Ogungbade (10.1016/j.yjmcc.2009.10.022_bib119) 2003; 285 Libby (10.1016/j.yjmcc.2009.10.022_bib25) 2002; 420 Zhang (10.1016/j.yjmcc.2009.10.022_bib82) 2008; 39 Katragadda (10.1016/j.yjmcc.2009.10.022_bib75) 2009; 46 Wang (10.1016/j.yjmcc.2009.10.022_bib40) 2002; 277 Lee (10.1016/j.yjmcc.2009.10.022_bib136) 2007; 17 Pasceri (10.1016/j.yjmcc.2009.10.022_bib39) 2000; 101 Sacerdoti (10.1016/j.yjmcc.2009.10.022_bib50) 2007; 82 Moshal (10.1016/j.yjmcc.2009.10.022_bib30) 2008; 215 Michaelis (10.1016/j.yjmcc.2009.10.022_bib88) 2005; 118 Zeldin (10.1016/j.yjmcc.2009.10.022_bib4) 2001; 276 Fang (10.1016/j.yjmcc.2009.10.022_bib7) 2001; 276 Davis (10.1016/j.yjmcc.2009.10.022_bib100) 2002; 99 Monti (10.1016/j.yjmcc.2009.10.022_bib19) 2008; 40 Webler (10.1016/j.yjmcc.2009.10.022_bib92) 2008; 28 Wang (10.1016/j.yjmcc.2009.10.022_bib126) 2003; 42 Gross (10.1016/j.yjmcc.2009.10.022_bib78) 2007; 42 Fornage (10.1016/j.yjmcc.2009.10.022_bib138) 2004; 109 Larsen (10.1016/j.yjmcc.2009.10.022_bib10) 2006; 290 Node (10.1016/j.yjmcc.2009.10.022_bib11) 1999; 285 Medhora (10.1016/j.yjmcc.2009.10.022_bib99) 2007; 82 Rendic (10.1016/j.yjmcc.2009.10.022_bib5) 1997; 29 Ng (10.1016/j.yjmcc.2009.10.022_bib44) 2007; 35 Inceoglu (10.1016/j.yjmcc.2009.10.022_bib61) 2008; 105 Ye (10.1016/j.yjmcc.2009.10.022_bib111) 2002; 303 Liu (10.1016/j.yjmcc.2009.10.022_bib45) 2004; 110 Sacerdoti (10.1016/j.yjmcc.2009.10.022_bib49) 2006; 291 Yaghi (10.1016/j.yjmcc.2009.10.022_bib118) 2004; 286 Smith (10.1016/j.yjmcc.2009.10.022_bib2) 1996; 271 Spector (10.1016/j.yjmcc.2009.10.022_bib8) 2004; 43 Fornage (10.1016/j.yjmcc.2009.10.022_bib139) 2005; 14 Pritchard (10.1016/j.yjmcc.2009.10.022_bib26) 1990; 167 Feige (10.1016/j.yjmcc.2009.10.022_bib36) 2006; 45 Fang (10.1016/j.yjmcc.2009.10.022_bib42) 2005; 314 |
| References_xml | – volume: 285 start-page: 1276 year: 1999 end-page: 1279 ident: bib11 article-title: Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids publication-title: Science – volume: 90 start-page: 1020 year: 2002 end-page: 1027 ident: bib101 article-title: Inhibition of vascular smooth muscle cell migration by cytochrome p450 epoxygenase-derived eicosanoids publication-title: Circ. Res. – volume: 52 start-page: 314 year: 2008 end-page: 323 ident: bib102 article-title: Soluble epoxide hydrolase inhibitors reduce the development of atherosclerosis in apolipoprotein e-knockout mouse model publication-title: J. Cardiovasc. Pharmacol. – volume: 280 start-page: 27138 year: 2005 end-page: 27146 ident: bib89 article-title: Characterization of 5,6- and 8,9-epoxyeicosatrienoic acids (5,6- and 8,9-EET) as potent in vivo angiogenic lipids publication-title: J. Biol. Chem. – volume: 314 start-page: 260 year: 2005 end-page: 270 ident: bib42 article-title: Activation of peroxisome proliferator-activated receptor alpha by substituted urea-derived soluble epoxide hydrolase inhibitors publication-title: J. Pharmacol. Exp. Ther. – volume: 40 start-page: 273 year: 2002 end-page: 279 ident: bib123 article-title: P450-dependent arachidonic acid metabolism and angiotensin II-induced renal damage publication-title: Hypertension – volume: 36 start-page: 205 year: 2008 end-page: 216 ident: bib129 article-title: Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer publication-title: Drug Metab. Dispos. – volume: 40 start-page: 529 year: 2008 end-page: 537 ident: bib19 article-title: Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease publication-title: Nat. Genet. – volume: 302 start-page: 406 year: 2003 end-page: 407 ident: bib37 article-title: Medicine. PPARs as therapeutic targets: reverse cardiology publication-title: Science – volume: 288 start-page: R188 year: 2005 end-page: R196 ident: bib125 article-title: Decreased epoxygenase and increased epoxide hydrolase expression in the mesenteric artery of obese Zucker rats publication-title: Am. J. Physiol. Regul. Integr. Comp. Physiol. – year: 2009 ident: bib79 article-title: Beneficial effects of soluble epoxide hydrolase inhibitors in myocardial infarction model: insight gained using metabolomic approaches publication-title: J. Mol. Cell. Cardiol. – volume: 291 start-page: H1999 year: 2006 end-page: H2002 ident: bib49 article-title: Rat mesenteric arterial dilator response to 11,12-epoxyeicosatrienoic acid is mediated by activating heme oxygenase publication-title: Am. J. Physiol. Heart Circ. Physiol. – volume: 164 start-page: 521 year: 2004 end-page: 532 ident: bib124 article-title: A peroxisome proliferator-activated receptor-alpha activator induces renal CYP2C23 activity and protects from angiotensin II-induced renal injury publication-title: Am. J. Pathol. – volume: 17 start-page: 349 year: 2007 end-page: 358 ident: bib136 article-title: CYP2J2 and CYP2C8 polymorphisms and coronary heart disease risk: the Atherosclerosis Risk in Communities (ARIC) study publication-title: Pharmacogenet. Genomics – volume: 90 start-page: 1028 year: 2002 end-page: 1036 ident: bib21 article-title: 14,15-Epoxyeicosa-5(Z)-enoic acid: a selective epoxyeicosatrienoic acid antagonist that inhibits endothelium-dependent hyperpolarization and relaxation in coronary arteries publication-title: Circ. Res. – volume: 285 start-page: F955 year: 2003 end-page: F964 ident: bib119 article-title: Role of epoxyeicosatrienoic acids in renal functional response to inhibition of NO production in the rat publication-title: Am. J. Physiol. Renal. Physiol. – volume: 32 start-page: 367 year: 2004 end-page: 375 ident: bib130 article-title: Transcriptional suppression of cytochrome P450 genes by endogenous and exogenous chemicals publication-title: Drug Metab. Dispos. – volume: 190 start-page: 26 year: 2007 end-page: 34 ident: bib140 article-title: Sequence variation in the soluble epoxide hydrolase gene and subclinical coronary atherosclerosis: interaction with cigarette smoking publication-title: Atherosclerosis – volume: 290 start-page: H55 year: 2006 end-page: H63 ident: bib43 article-title: 14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-alpha publication-title: Am. J. Physiol. Heart Circ. Physiol. – volume: 171 start-page: 184 year: 2001 end-page: 193 ident: bib109 article-title: The role of methyl-linoleic acid epoxide and diol metabolites in the amplified toxicity of linoleic acid and polychlorinated biphenyls to vascular endothelial cells publication-title: Toxicol. Appl. Pharmacol. – volume: 29 start-page: 207 year: 2001 end-page: 212 ident: bib128 article-title: Regulation of cytochrome p450 by inflammatory mediators: why and how? publication-title: Drug Metab. Dispos. – volume: 442 start-page: 511 year: 2001 end-page: 518 ident: bib83 article-title: The coronary endothelium-derived hyperpolarizing factor (EDHF) stimulates multiple signalling pathways and proliferation in vascular cells publication-title: Pflugers. Arch. – volume: 29 start-page: 1265 year: 2009 end-page: 1270 ident: bib103 article-title: Inhibition of soluble epoxide hydrolase attenuated atherosclerosis, abdominal aortic aneurysm formation, and dyslipidemia publication-title: Arterioscler. Thromb. Vasc. Biol. – volume: 70 start-page: 2521 year: 2002 end-page: 2533 ident: bib31 article-title: Effects of epoxyeicosatrienoic acids on polymorphonuclear leukocyte function publication-title: Life Sci. – volume: 41 start-page: 709 year: 2003 end-page: 714 ident: bib122 article-title: Decreased renal cytochrome P450 2C enzymes and impaired vasodilation are associated with angiotensin salt-sensitive hypertension publication-title: Hypertension – volume: 111 start-page: 5581 year: 2008 end-page: 5591 ident: bib95 article-title: An essential role for SRC-activated STAT-3 in 14,15-EET-induced VEGF expression and angiogenesis publication-title: Blood – volume: 118 start-page: 5489 year: 2005 end-page: 5498 ident: bib88 article-title: Cytochrome P450 epoxygenases 2C8 and 2C9 are implicated in hypoxia-induced endothelial cell migration and angiogenesis publication-title: J. Cell. Sci. – volume: 28 start-page: 1123 year: 2008 end-page: 1129 ident: bib92 article-title: Cytochrome P450 2C9-induced angiogenesis is dependent on EphB4 publication-title: Arterioscler. Thromb. Vasc. Biol. – volume: 102 start-page: 9772 year: 2005 end-page: 9777 ident: bib22 article-title: Soluble epoxide hydrolase is a therapeutic target for acute inflammation publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 32 start-page: 1186 year: 2004 end-page: 1191 ident: bib116 article-title: Differential expression of cytochrome P450 isoforms in the lungs of septic animals publication-title: Crit. Care Med. – volume: 275 start-page: 40504 year: 2000 end-page: 40510 ident: bib15 article-title: Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation publication-title: J. Biol. Chem. – volume: 271 start-page: 3460 year: 1996 end-page: 3468 ident: bib6 article-title: Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart publication-title: J. Biol. Chem. – volume: 87 start-page: 992 year: 2000 end-page: 998 ident: bib18 article-title: Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids publication-title: Circ. Res. – volume: 60 start-page: 310 year: 2001 end-page: 320 ident: bib70 article-title: Overexpression of cytochrome P450 CYP2J2 protects against hypoxia-reoxygenation injury in cultured bovine aortic endothelial cells publication-title: Mol. Pharmacol. – volume: 29 start-page: 413 year: 1997 end-page: 580 ident: bib5 article-title: Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors publication-title: Drug Metab. Rev. – volume: 88 start-page: 44 year: 2001 end-page: 51 ident: bib27 article-title: Endothelium-derived hyperpolarizing factor synthase (cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries publication-title: Circ. Res. – volume: 64 start-page: 482 year: 2003 end-page: 490 ident: bib137 article-title: Polymorphisms in human soluble epoxide hydrolase publication-title: Mol. Pharmacol. – volume: 420 start-page: 868 year: 2002 end-page: 874 ident: bib25 article-title: Inflammation in atherosclerosis publication-title: Nature – volume: 276 start-page: 15983 year: 2001 end-page: 15989 ident: bib65 article-title: Activation of Galphas mediates induction of tissue-type plasminogen activator gene transcription by epoxyeicosatrienoic acids publication-title: J. Biol. Chem. – volume: 21 start-page: 308 year: 2005 end-page: 313 ident: bib127 article-title: Tobacco smoke dysregulates endothelial vasoregulatory transcripts in vivo publication-title: Physiol. Genomics – volume: 167 start-page: 137 year: 1990 end-page: 142 ident: bib26 article-title: 14, 15-Epoxyeicosatrienoic acid promotes endothelial cell dependent adhesion of human monocytic tumor U937 cells publication-title: Biochem. Biophys. Res. Commun. – volume: 94 start-page: 3341 year: 1996 end-page: 3347 ident: bib53 article-title: Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor publication-title: Circulation – volume: 99 start-page: 2222 year: 2002 end-page: 2227 ident: bib100 article-title: Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 195 start-page: 199 year: 2007 end-page: 206 ident: bib133 article-title: Synergistic effect of cytochrome P450 epoxygenase CYP2J2⁎7 polymorphism with smoking on the onset of premature myocardial infarction publication-title: Atherosclerosis – volume: 102 start-page: 16747 year: 2005 end-page: 16752 ident: bib29 article-title: The antiinflammatory effect of laminar flow: the role of PPARgamma, epoxyeicosatrienoic acids, and soluble epoxide hydrolase publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 300 start-page: 115 year: 1993 end-page: 123 ident: bib52 article-title: Inhibition of cytochromes P450 by nitric oxide and a nitric oxide-releasing agent publication-title: Arch. Biochem. Biophys. – volume: 268 start-page: 12260 year: 1993 end-page: 12266 ident: bib63 article-title: Renal vasodilator activity of 5,6-epoxyeicosatrienoic acid depends upon conversion by cyclooxygenase and release of prostaglandins publication-title: J. Biol. Chem. – volume: 25 start-page: 321 year: 2005 end-page: 326 ident: bib64 article-title: Cytochrome P4502C9-derived epoxyeicosatrienoic acids induce the expression of cyclooxygenase-2 in endothelial cells publication-title: Arterioscler. Thromb. Vasc. Biol. – volume: 14 start-page: 2829 year: 2005 end-page: 2837 ident: bib139 article-title: The soluble epoxide hydrolase gene harbors sequence variation associated with susceptibility to and protection from incident ischemic stroke publication-title: Hum. Mol. Genet. – volume: 109 start-page: 178 year: 2004 end-page: 183 ident: bib106 article-title: Inhibition of cytochrome P450 2C9 improves endothelium-dependent, nitric oxide-mediated vasodilatation in patients with coronary artery disease publication-title: Circulation – volume: 13 start-page: 715 year: 2003 end-page: 720 ident: bib135 article-title: Allelic variants of cytochromes P450 2C modify the risk for acute myocardial infarction publication-title: Pharmacogenetics – volume: 110 start-page: 2132 year: 2004 end-page: 2136 ident: bib132 article-title: Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2 publication-title: Circulation – volume: 275 start-page: H2113 year: 1998 end-page: 2121 ident: bib59 article-title: 14,15-Epoxyeicosatrienoic acid inhibits prostaglandin E2 production in vascular smooth muscle cells publication-title: Am. J. Physiol. – volume: 42 start-page: 594 year: 2003 end-page: 599 ident: bib126 article-title: Downregulation of renal CYP-derived eicosanoid synthesis in rats with diet-induced hypertension publication-title: Hypertension – volume: 215 start-page: 771 year: 2008 end-page: 781 ident: bib30 article-title: Cytochrome P450 (CYP) 2J2 gene transfection attenuates MMP-9 via inhibition of NF-kappabeta in hyperhomocysteinemia publication-title: J. Cell. Physiol. – volume: 103 start-page: 18733 year: 2006 end-page: 18738 ident: bib34 article-title: Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 274 start-page: 23679 year: 1999 end-page: 23682 ident: bib1 article-title: Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate publication-title: J. Biol. Chem. – volume: 24 start-page: 595 year: 2004 end-page: 600 ident: bib68 article-title: Membrane-potential-dependent inhibition of platelet adhesion to endothelial cells by epoxyeicosatrienoic acids publication-title: Arterioscler. Thromb. Vasc. Biol. – volume: 104 start-page: 9018 year: 2007 end-page: 9023 ident: bib120 article-title: Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 285 start-page: L1099 year: 2003 end-page: L1105 ident: bib117 article-title: Pulmonary cytochrome P-450 2J4 is reduced in a rat model of acute Pseudomonas pneumonia publication-title: Am. J. Physiol. Lung Cell Mol. Physiol. – volume: 8 start-page: 1369 year: 2007 end-page: 1383 ident: bib131 article-title: Genetic variation in the cytochrome P450 epoxygenase pathway and cardiovascular disease risk publication-title: Pharmacogenomics – volume: 83 start-page: 362 year: 2009 end-page: 370 ident: bib80 article-title: Role of B-type natriuretic peptide in epoxyeicosatrienoic acid-mediated improved post-ischaemic recovery of heart contractile function publication-title: Cardiovasc. Res. – volume: 47 start-page: 557 year: 2006 end-page: 562 ident: bib121 article-title: Tumor necrosis factor alpha blockade increases renal Cyp2c23 expression and slows the progression of renal damage in salt-sensitive hypertension publication-title: Hypertension – volume: 82 start-page: 155 year: 2007 end-page: 161 ident: bib50 article-title: 11,12-Epoxyeicosatrienoic acid stimulates heme-oxygenase-1 in endothelial cells publication-title: Prostaglandins Other Lipid Mediat. – volume: 9 start-page: 3339 year: 2004 end-page: 3355 ident: bib58 article-title: Non-prostaglandin eicosanoids in fever and anapyrexia publication-title: Front. Biosci. – volume: 39 start-page: 609 year: 2002 end-page: 613 ident: bib112 article-title: Cytochrome P450-dependent eicosapentaenoic acid metabolites are novel BK channel activators publication-title: Hypertension – volume: 29 start-page: 54 year: 2009 end-page: 60 ident: bib55 article-title: Interaction between P450 eicosanoids and nitric oxide in the control of arterial tone in mice publication-title: Arterioscler. Thromb. Vasc. Biol. – volume: 103 start-page: 13646 year: 2006 end-page: 13651 ident: bib60 article-title: Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitors publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 35 start-page: 1126 year: 2007 end-page: 1134 ident: bib44 article-title: Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha publication-title: Drug. Metab. Dispos. – volume: 82 start-page: 19 year: 2007 end-page: 29 ident: bib99 article-title: Emerging mechanisms for growth and protection of the vasculature by cytochrome P450-derived products of arachidonic acid and other eicosanoids publication-title: Prostaglandins Other Lipid Mediat. – volume: 295 start-page: H2128 year: 2008 end-page: H2134 ident: bib76 article-title: Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia–reperfusion injury in vivo publication-title: Am. J. Physiol. Heart Circ. Physiol. – volume: 297 start-page: F740 year: 2009 end-page: F748 ident: bib16 article-title: Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension publication-title: Am. J. Physiol. Renal. Physiol. – volume: 243 start-page: 388 year: 1989 end-page: 390 ident: bib48 article-title: Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats publication-title: Science – volume: 11 start-page: 597 year: 2001 end-page: 607 ident: bib134 article-title: Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid publication-title: Pharmacogenetics – volume: 39 start-page: 690 year: 2002 end-page: 694 ident: bib17 article-title: Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension publication-title: Hypertension – volume: 82 start-page: 131 year: 2002 end-page: 185 ident: bib3 article-title: P-450 metabolites of arachidonic acid in the control of cardiovascular function publication-title: Physiol. Rev. – volume: 109 start-page: 335 year: 2004 end-page: 339 ident: bib138 article-title: Polymorphism of the soluble epoxide hydrolase is associated with coronary artery calcification in African–American subjects: the Coronary Artery Risk Development in Young Adults (CARDIA) study publication-title: Circulation – volume: 284 start-page: C422 year: 2003 end-page: C428 ident: bib104 article-title: TNF-alpha -induced endothelial cell adhesion molecule expression is cytochrome P-450 monooxygenase dependent publication-title: Am. J. Physiol. Cell. Physiol. – volume: 45 start-page: 120 year: 2006 end-page: 159 ident: bib36 article-title: From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions publication-title: Prog. Lipid. Res. – volume: 67 start-page: 6665 year: 2007 end-page: 6674 ident: bib94 article-title: Cytochrome p450 epoxygenase promotes human cancer metastasis publication-title: Cancer Res. – volume: 329 start-page: 1275 year: 2005 end-page: 1281 ident: bib110 article-title: Eicosapentaenoic acid metabolism by cytochrome P450 enzymes of the CYP2C subfamily publication-title: Biochem. Biophys. Res. Commun. – volume: 294 start-page: H724 year: 2008 end-page: H735 ident: bib71 article-title: Multiple antiapoptotic targets of the PI3K/Akt survival pathway are activated by epoxyeicosatrienoic acids to protect cardiomyocytes from hypoxia/anoxia publication-title: Am. J. Physiol. Heart Circ. Physiol. – volume: 293 start-page: H142 year: 2007 end-page: H151 ident: bib97 article-title: Cytochrome P-450 epoxygenases protect endothelial cells from apoptosis induced by tumor necrosis factor-alpha via MAPK and PI3K/Akt signaling pathways publication-title: Am. J. Physiol. Heart Circ. Physiol. – volume: 793 start-page: 408 year: 1984 end-page: 415 ident: bib62 article-title: Metabolism of 5(6)-expoxyeicosatrienoic acid by ram seminal vesicles. Formation of novel prostaglandin E1 metabolites publication-title: Biochim. Biophys. Acta. – volume: 277 start-page: 15671 year: 2002 end-page: 15676 ident: bib84 article-title: Cytochrome P450 2C9-induced endothelial cell proliferation involves induction of mitogen-activated protein (MAP) kinase phosphatase-1, inhibition of the c-Jun N-terminal kinase, and up-regulation of cyclin D1 publication-title: J. Biol. Chem. – volume: 25 start-page: 904 year: 2005 end-page: 914 ident: bib32 article-title: Nuclear factor kappaB signaling in atherogenesis publication-title: Arterioscler. Thromb. Vasc. Biol. – volume: 97 start-page: 263 year: 2007 end-page: 271 ident: bib66 article-title: Acute tissue-type plasminogen activator release in human microvascular endothelial cells: the roles of Galphaq, PLC-beta, IP3 and 5,6-epoxyeicosatrienoic acid publication-title: Thromb. Haemost. – volume: 39 start-page: 2073 year: 2008 end-page: 2078 ident: bib82 article-title: Soluble epoxide hydrolase gene deletion is protective against experimental cerebral ischemia publication-title: Stroke – volume: 276 start-page: 36059 year: 2001 end-page: 36062 ident: bib4 article-title: Epoxygenase pathways of arachidonic acid metabolism publication-title: J. Biol. Chem. – volume: 93 start-page: 148 year: 2008 end-page: 154 ident: bib38 article-title: Epoxygenases and peroxisome proliferator-activated receptors in mammalian vascular biology publication-title: Exp. Physiol. – volume: 290 start-page: 1250 year: 1999 end-page: 1257 ident: bib115 article-title: Modulation of cytochrome P-450 gene expression in endotoxemic mice is tissue specific and peroxisome proliferator-activated receptor-alpha dependent publication-title: J. Pharmacol. Exp. Ther. – volume: 99 start-page: 442 year: 2006 end-page: 450 ident: bib24 article-title: Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function publication-title: Circ. Res. – volume: 303 start-page: 768 year: 2002 end-page: 776 ident: bib111 article-title: Cytochrome p-450 epoxygenase metabolites of docosahexaenoate potently dilate coronary arterioles by activating large-conductance calcium-activated potassium channels publication-title: J. Pharmacol. Exp. Ther. – volume: 46 start-page: 978 year: 2009 end-page: 988 ident: bib72 article-title: Protective actions of epoxyeicosatrienoic acid: dual targeting of cardiovascular PI3K and KATP channels publication-title: J. Mol. Cell. Cardiol. – volume: 96 start-page: 2676 year: 1995 end-page: 2682 ident: bib47 article-title: Endothelial cell expression of vasoconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide publication-title: J. Clin. Invest. – volume: 78 start-page: 415 year: 1996 end-page: 423 ident: bib12 article-title: Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors publication-title: Circ. Res. – volume: 43 start-page: 55 year: 2004 end-page: 90 ident: bib8 article-title: Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function publication-title: Prog. Lipid Res. – volume: 100 start-page: 1703 year: 2007 end-page: 1711 ident: bib46 article-title: Heme oxygenase-1 expression in macrophages plays a beneficial role in atherosclerosis publication-title: Circ. Res. – volume: 307 start-page: 753 year: 2003 end-page: 764 ident: bib54 article-title: Up-regulation of endothelial nitric-oxide synthase by endothelium-derived hyperpolarizing factor involves mitogen-activated protein kinase and protein kinase C signaling pathways publication-title: J. Pharmacol. Exp. Ther. – volume: 261 start-page: 15334 year: 1986 end-page: 15338 ident: bib67 article-title: Inhibition of cyclooxygenase activity and platelet aggregation by epoxyeicosatrienoic acids. Influence of stereochemistry publication-title: J. Biol. Chem. – volume: 314 start-page: 522 year: 2005 end-page: 532 ident: bib90 article-title: Arachidonic acid epoxygenase metabolites stimulate endothelial cell growth and angiogenesis via mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways publication-title: J. Pharmacol. Exp. Ther. – volume: 277 start-page: 34176 year: 2002 end-page: 34181 ident: bib40 article-title: Constitutive activation of peroxisome proliferator-activated receptor-gamma suppresses pro-inflammatory adhesion molecules in human vascular endothelial cells publication-title: J. Biol. Chem. – volume: 13 start-page: 4011 year: 2003 end-page: 4014 ident: bib28 article-title: 11,12-Epoxyeicosatrienoic acid (11,12-EET): structural determinants for inhibition of TNF-alpha-induced VCAM-1 expression publication-title: Bioorg. Med. Chem. Lett. – volume: 38 start-page: 192 year: 2008 end-page: 201 ident: bib33 article-title: EET displays anti-inflammatory effects in TNF-alpha stimulated human bronchi: putative role of CPI-17 publication-title: Am. J. Respir. Cell. Mol. Biol. – volume: 105 start-page: 18901 year: 2008 end-page: 18906 ident: bib61 article-title: Soluble epoxide hydrolase and epoxyeicosatrienoic acids modulate two distinct analgesic pathways publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 281 start-page: 905 year: 2006 end-page: 914 ident: bib91 article-title: Fibroblast growth factor-2 is a downstream mediator of phosphatidylinositol 3-kinase-Akt signaling in 14,15-epoxyeicosatrienoic acid-induced angiogenesis publication-title: J. Biol. Chem. – volume: 271 start-page: 33157 year: 1996 end-page: 33160 ident: bib2 article-title: Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2 publication-title: J. Biol. Chem. – volume: 24 start-page: 401 year: 1996 end-page: 407 ident: bib114 article-title: Endotoxemia in rats is associated with induction of the P4504A subfamily and suppression of several other forms of cytochrome P450 publication-title: Drug. Metab. Dispos. – volume: 278 start-page: 29619 year: 2003 end-page: 29625 ident: bib85 article-title: 11,12-Epoxyeicosatrienoic acid-induced inhibition of FOXO factors promotes endothelial proliferation by down-regulating p27Kip1 publication-title: J. Biol. Chem. – volume: 286 start-page: L1260 year: 2004 end-page: L1267 ident: bib118 article-title: Excess nitric oxide decreases cytochrome P-450 2J4 content and P-450-dependent arachidonic acid metabolism in lungs of rats with acute pneumonia publication-title: Am. J. Physiol. Lung Cell Mol. Physiol. – volume: 282 start-page: 2891 year: 2007 end-page: 2898 ident: bib23 article-title: Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted mice publication-title: J. Biol. Chem. – volume: 284 start-page: H215 year: 2003 end-page: H224 ident: bib86 article-title: Epoxygenase-driven angiogenesis in human lung microvascular endothelial cells publication-title: Am. J. Physiol. Heart Circ. Physiol. – volume: 228 start-page: 786 year: 2003 end-page: 794 ident: bib57 article-title: 11,12-Epoxyeicosatrienoic acid attenuates synthesis of prostaglandin E2 in rat monocytes stimulated with lipopolysaccharide publication-title: Exp. Biol. Med. (Maywood) – volume: 101 start-page: 1321 year: 2004 end-page: 1326 ident: bib105 article-title: Reduction of ischemia and reperfusion-induced myocardial damage by cytochrome P450 inhibitors publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 44 start-page: 707 year: 1993 end-page: 715 ident: bib113 article-title: Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture publication-title: Mol. Pharmacol. – volume: 110 start-page: 1128 year: 2004 end-page: 1133 ident: bib45 article-title: Laminar flow activates peroxisome proliferator-activated receptor-gamma in vascular endothelial cells publication-title: Circulation – volume: 291 start-page: H537 year: 2006 end-page: H542 ident: bib77 article-title: Epoxyeicosatrienoic acids in cardioprotection: ischemic versus reperfusion injury publication-title: Am. J. Physiol. Heart Circ. Physiol. – volume: 291 start-page: H517 year: 2006 end-page: H531 ident: bib96 article-title: Protective effects of epoxyeicosatrienoic acids on human endothelial cells from the pulmonary and coronary vasculature publication-title: Am. J. Physiol. Heart Circ. Physiol. – volume: 102 start-page: 2186 year: 2005 end-page: 2191 ident: bib35 article-title: Attenuation of tobacco smoke-induced lung inflammation by treatment with a soluble epoxide hydrolase inhibitor publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 101 start-page: 235 year: 2000 end-page: 238 ident: bib39 article-title: Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators publication-title: Circulation – volume: 15 start-page: 1640 year: 2006 end-page: 1649 ident: bib107 article-title: Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study publication-title: Hum. Mol. Genet. – volume: 82 start-page: 50 year: 2007 end-page: 59 ident: bib69 article-title: Role of epoxyeicosatrienoic acids in protecting the myocardium following ischemia/reperfusion injury publication-title: Prostaglandins Other Lipid Mediat. – volume: 329 start-page: 908 year: 2009 end-page: 918 ident: bib98 article-title: Selective inhibitors of CYP2J2 related to terfenadine exhibit strong activity against human cancers in vitro and in vivo publication-title: J. Pharmacol. Exp. Ther. – volume: 46 start-page: 842 year: 2005 end-page: 848 ident: bib81 article-title: An epoxide hydrolase inhibitor, 12-(3-adamantan-1-yl-ureido)dodecanoic acid (AUDA), reduces ischemic cerebral infarct size in stroke-prone spontaneously hypertensive rats publication-title: J. Cardiovasc. Pharmacol. – volume: 46 start-page: 867 year: 2009 end-page: 875 ident: bib75 article-title: Epoxyeicosatrienoic acids limit damage to mitochondrial function following stress in cardiac cells publication-title: J. Mol. Cell. Cardiol. – volume: 295 start-page: C1292 year: 2008 end-page: C1301 ident: bib93 article-title: Epoxyeicosatrienoic acids are part of the VEGF-activated signaling cascade leading to angiogenesis publication-title: Am. J. Physiol. Cell. Physiol. – volume: 401 start-page: 493 year: 1999 end-page: 497 ident: bib13 article-title: Cytochrome P450 2C is an EDHF synthase in coronary arteries publication-title: Nature – volume: 26 start-page: 1215 year: 2006 end-page: 1225 ident: bib14 article-title: Endothelium-derived hyperpolarizing factor: where are we now? publication-title: Arterioscler. Thromb. Vasc. Biol. – volume: 276 start-page: 14867 year: 2001 end-page: 14874 ident: bib7 article-title: Pathways of epoxyeicosatrienoic acid metabolism in endothelial cells. Implications for the vascular effects of soluble epoxide hydrolase inhibition publication-title: J. Biol. Chem. – volume: 308 start-page: 51 year: 2008 end-page: 56 ident: bib56 article-title: 11,12-Epoxyeicosatrienoic acid activates the l-arginine/nitric oxide pathway in human platelets publication-title: Mol. Cell. Biochem. – volume: 17 start-page: 770 year: 2003 end-page: 772 ident: bib87 article-title: Cytochrome P450 2C9-derived epoxyeicosatrienoic acids induce angiogenesis via cross-talk with the epidermal growth factor receptor (EGFR) publication-title: FASEB J. – volume: 42 start-page: 687 year: 2007 end-page: 691 ident: bib78 article-title: Mechanisms by which epoxyeicosatrienoic acids (EETs) elicit cardioprotection in rat hearts publication-title: J. Mol. Cell. Cardiol. – volume: 290 start-page: H491 year: 2006 end-page: H499 ident: bib10 article-title: Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BK(Ca) channels: implications for soluble epoxide hydrolase inhibition publication-title: Am. J. Physiol. Heart Circ. Physiol. – volume: 277 start-page: 35105 year: 2002 end-page: 35112 ident: bib41 article-title: The CYP4A isoforms hydroxylate epoxyeicosatrienoic acids to form high affinity peroxisome proliferator-activated receptor ligands publication-title: J. Biol. Chem. – volume: 293 start-page: 494 year: 2000 end-page: 500 ident: bib51 article-title: Adenoviral vector-mediated transfer of human heme oxygenase in rats decreases renal heme-dependent arachidonic acid epoxygenase activity publication-title: J. Pharmacol. Exp. Ther. – volume: 3 start-page: 562 year: 1997 end-page: 566 ident: bib108 article-title: Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase publication-title: Nat. Med. – volume: 82 start-page: 60 year: 2007 end-page: 67 ident: bib20 article-title: Epoxyeicosatrienoic acids, cell signaling and angiogenesis publication-title: Prostaglandins Other Lipid Mediat. – volume: 95 start-page: 506 year: 2004 end-page: 514 ident: bib73 article-title: Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and p42/p44 MAPK pathway publication-title: Circ. Res. – volume: 46 start-page: 67 year: 2009 end-page: 74 ident: bib74 article-title: Epoxyeicosatrienoic acid prevents postischemic electrocardiogram abnormalities in an isolated heart model publication-title: J. Mol. Cell. Cardiol. – volume: 52 start-page: 447 year: 2004 end-page: 454 ident: bib9 article-title: Distribution of soluble epoxide hydrolase and of cytochrome P450 2C8, 2C9, and 2J2 in human tissues publication-title: J. Histochem. Cytochem. – volume: 294 start-page: H724 year: 2008 ident: 10.1016/j.yjmcc.2009.10.022_bib71 article-title: Multiple antiapoptotic targets of the PI3K/Akt survival pathway are activated by epoxyeicosatrienoic acids to protect cardiomyocytes from hypoxia/anoxia publication-title: Am. J. Physiol. Heart Circ. Physiol. doi: 10.1152/ajpheart.00979.2007 – volume: 420 start-page: 868 year: 2002 ident: 10.1016/j.yjmcc.2009.10.022_bib25 article-title: Inflammation in atherosclerosis publication-title: Nature doi: 10.1038/nature01323 – volume: 105 start-page: 18901 year: 2008 ident: 10.1016/j.yjmcc.2009.10.022_bib61 article-title: Soluble epoxide hydrolase and epoxyeicosatrienoic acids modulate two distinct analgesic pathways publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.0809765105 – volume: 13 start-page: 4011 year: 2003 ident: 10.1016/j.yjmcc.2009.10.022_bib28 article-title: 11,12-Epoxyeicosatrienoic acid (11,12-EET): structural determinants for inhibition of TNF-alpha-induced VCAM-1 expression publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2003.08.060 – volume: 42 start-page: 594 year: 2003 ident: 10.1016/j.yjmcc.2009.10.022_bib126 article-title: Downregulation of renal CYP-derived eicosanoid synthesis in rats with diet-induced hypertension publication-title: Hypertension doi: 10.1161/01.HYP.0000090123.55365.BA – volume: 29 start-page: 413 year: 1997 ident: 10.1016/j.yjmcc.2009.10.022_bib5 article-title: Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors publication-title: Drug Metab. Rev. doi: 10.3109/03602539709037591 – volume: 82 start-page: 50 year: 2007 ident: 10.1016/j.yjmcc.2009.10.022_bib69 article-title: Role of epoxyeicosatrienoic acids in protecting the myocardium following ischemia/reperfusion injury publication-title: Prostaglandins Other Lipid Mediat. doi: 10.1016/j.prostaglandins.2006.05.017 – volume: 291 start-page: H517 year: 2006 ident: 10.1016/j.yjmcc.2009.10.022_bib96 article-title: Protective effects of epoxyeicosatrienoic acids on human endothelial cells from the pulmonary and coronary vasculature publication-title: Am. J. Physiol. Heart Circ. Physiol. doi: 10.1152/ajpheart.00953.2005 – volume: 104 start-page: 9018 year: 2007 ident: 10.1016/j.yjmcc.2009.10.022_bib120 article-title: Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.0703229104 – volume: 8 start-page: 1369 year: 2007 ident: 10.1016/j.yjmcc.2009.10.022_bib131 article-title: Genetic variation in the cytochrome P450 epoxygenase pathway and cardiovascular disease risk publication-title: Pharmacogenomics doi: 10.2217/14622416.8.10.1369 – volume: 29 start-page: 54 year: 2009 ident: 10.1016/j.yjmcc.2009.10.022_bib55 article-title: Interaction between P450 eicosanoids and nitric oxide in the control of arterial tone in mice publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/ATVBAHA.108.171298 – volume: 284 start-page: H215 year: 2003 ident: 10.1016/j.yjmcc.2009.10.022_bib86 article-title: Epoxygenase-driven angiogenesis in human lung microvascular endothelial cells publication-title: Am. J. Physiol. Heart Circ. Physiol. doi: 10.1152/ajpheart.01118.2001 – volume: 286 start-page: L1260 year: 2004 ident: 10.1016/j.yjmcc.2009.10.022_bib118 article-title: Excess nitric oxide decreases cytochrome P-450 2J4 content and P-450-dependent arachidonic acid metabolism in lungs of rats with acute pneumonia publication-title: Am. J. Physiol. Lung Cell Mol. Physiol. doi: 10.1152/ajplung.00273.2003 – volume: 70 start-page: 2521 year: 2002 ident: 10.1016/j.yjmcc.2009.10.022_bib31 article-title: Effects of epoxyeicosatrienoic acids on polymorphonuclear leukocyte function publication-title: Life Sci. doi: 10.1016/S0024-3205(02)01533-3 – volume: 278 start-page: 29619 year: 2003 ident: 10.1016/j.yjmcc.2009.10.022_bib85 article-title: 11,12-Epoxyeicosatrienoic acid-induced inhibition of FOXO factors promotes endothelial proliferation by down-regulating p27Kip1 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M305385200 – volume: 288 start-page: R188 year: 2005 ident: 10.1016/j.yjmcc.2009.10.022_bib125 article-title: Decreased epoxygenase and increased epoxide hydrolase expression in the mesenteric artery of obese Zucker rats publication-title: Am. J. Physiol. Regul. Integr. Comp. Physiol. doi: 10.1152/ajpregu.00018.2004 – volume: 90 start-page: 1028 year: 2002 ident: 10.1016/j.yjmcc.2009.10.022_bib21 article-title: 14,15-Epoxyeicosa-5(Z)-enoic acid: a selective epoxyeicosatrienoic acid antagonist that inhibits endothelium-dependent hyperpolarization and relaxation in coronary arteries publication-title: Circ. Res. doi: 10.1161/01.RES.0000018162.87285.F8 – volume: 308 start-page: 51 year: 2008 ident: 10.1016/j.yjmcc.2009.10.022_bib56 article-title: 11,12-Epoxyeicosatrienoic acid activates the l-arginine/nitric oxide pathway in human platelets publication-title: Mol. Cell. Biochem. doi: 10.1007/s11010-007-9611-6 – volume: 95 start-page: 506 year: 2004 ident: 10.1016/j.yjmcc.2009.10.022_bib73 article-title: Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and p42/p44 MAPK pathway publication-title: Circ. Res. doi: 10.1161/01.RES.0000139436.89654.c8 – volume: 29 start-page: 207 year: 2001 ident: 10.1016/j.yjmcc.2009.10.022_bib128 article-title: Regulation of cytochrome p450 by inflammatory mediators: why and how? publication-title: Drug Metab. Dispos. – volume: 164 start-page: 521 year: 2004 ident: 10.1016/j.yjmcc.2009.10.022_bib124 article-title: A peroxisome proliferator-activated receptor-alpha activator induces renal CYP2C23 activity and protects from angiotensin II-induced renal injury publication-title: Am. J. Pathol. doi: 10.1016/S0002-9440(10)63142-2 – volume: 94 start-page: 3341 year: 1996 ident: 10.1016/j.yjmcc.2009.10.022_bib53 article-title: Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor publication-title: Circulation doi: 10.1161/01.CIR.94.12.3341 – volume: 307 start-page: 753 year: 2003 ident: 10.1016/j.yjmcc.2009.10.022_bib54 article-title: Up-regulation of endothelial nitric-oxide synthase by endothelium-derived hyperpolarizing factor involves mitogen-activated protein kinase and protein kinase C signaling pathways publication-title: J. Pharmacol. Exp. Ther. doi: 10.1124/jpet.103.052787 – volume: 171 start-page: 184 year: 2001 ident: 10.1016/j.yjmcc.2009.10.022_bib109 article-title: The role of methyl-linoleic acid epoxide and diol metabolites in the amplified toxicity of linoleic acid and polychlorinated biphenyls to vascular endothelial cells publication-title: Toxicol. Appl. Pharmacol. doi: 10.1006/taap.2001.9131 – volume: 261 start-page: 15334 year: 1986 ident: 10.1016/j.yjmcc.2009.10.022_bib67 article-title: Inhibition of cyclooxygenase activity and platelet aggregation by epoxyeicosatrienoic acids. Influence of stereochemistry publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(18)66872-3 – volume: 32 start-page: 1186 year: 2004 ident: 10.1016/j.yjmcc.2009.10.022_bib116 article-title: Differential expression of cytochrome P450 isoforms in the lungs of septic animals publication-title: Crit. Care Med. doi: 10.1097/01.CCM.0000124877.86743.37 – volume: 110 start-page: 2132 year: 2004 ident: 10.1016/j.yjmcc.2009.10.022_bib132 article-title: Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2 publication-title: Circulation doi: 10.1161/01.CIR.0000143832.91812.60 – volume: 28 start-page: 1123 year: 2008 ident: 10.1016/j.yjmcc.2009.10.022_bib92 article-title: Cytochrome P450 2C9-induced angiogenesis is dependent on EphB4 publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/ATVBAHA.107.161190 – volume: 274 start-page: 23679 year: 1999 ident: 10.1016/j.yjmcc.2009.10.022_bib1 article-title: Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate publication-title: J. Biol. Chem. doi: 10.1074/jbc.274.34.23679 – volume: 215 start-page: 771 year: 2008 ident: 10.1016/j.yjmcc.2009.10.022_bib30 article-title: Cytochrome P450 (CYP) 2J2 gene transfection attenuates MMP-9 via inhibition of NF-kappabeta in hyperhomocysteinemia publication-title: J. Cell. Physiol. doi: 10.1002/jcp.21356 – volume: 24 start-page: 595 year: 2004 ident: 10.1016/j.yjmcc.2009.10.022_bib68 article-title: Membrane-potential-dependent inhibition of platelet adhesion to endothelial cells by epoxyeicosatrienoic acids publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/01.ATV.0000116219.09040.8c – volume: 793 start-page: 408 year: 1984 ident: 10.1016/j.yjmcc.2009.10.022_bib62 article-title: Metabolism of 5(6)-expoxyeicosatrienoic acid by ram seminal vesicles. Formation of novel prostaglandin E1 metabolites publication-title: Biochim. Biophys. Acta. doi: 10.1016/0005-2760(84)90256-X – volume: 271 start-page: 3460 year: 1996 ident: 10.1016/j.yjmcc.2009.10.022_bib6 article-title: Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart publication-title: J. Biol. Chem. doi: 10.1074/jbc.271.7.3460 – volume: 190 start-page: 26 year: 2007 ident: 10.1016/j.yjmcc.2009.10.022_bib140 article-title: Sequence variation in the soluble epoxide hydrolase gene and subclinical coronary atherosclerosis: interaction with cigarette smoking publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2006.02.021 – volume: 275 start-page: 40504 year: 2000 ident: 10.1016/j.yjmcc.2009.10.022_bib15 article-title: Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation publication-title: J. Biol. Chem. doi: 10.1074/jbc.M008106200 – volume: 82 start-page: 60 year: 2007 ident: 10.1016/j.yjmcc.2009.10.022_bib20 article-title: Epoxyeicosatrienoic acids, cell signaling and angiogenesis publication-title: Prostaglandins Other Lipid Mediat. doi: 10.1016/j.prostaglandins.2006.05.003 – volume: 329 start-page: 908 year: 2009 ident: 10.1016/j.yjmcc.2009.10.022_bib98 article-title: Selective inhibitors of CYP2J2 related to terfenadine exhibit strong activity against human cancers in vitro and in vivo publication-title: J. Pharmacol. Exp. Ther. doi: 10.1124/jpet.109.152017 – volume: 293 start-page: 494 year: 2000 ident: 10.1016/j.yjmcc.2009.10.022_bib51 article-title: Adenoviral vector-mediated transfer of human heme oxygenase in rats decreases renal heme-dependent arachidonic acid epoxygenase activity publication-title: J. Pharmacol. Exp. Ther. doi: 10.1016/S0022-3565(24)39260-2 – volume: 271 start-page: 33157 year: 1996 ident: 10.1016/j.yjmcc.2009.10.022_bib2 article-title: Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2 publication-title: J. Biol. Chem. doi: 10.1074/jbc.271.52.33157 – volume: 280 start-page: 27138 year: 2005 ident: 10.1016/j.yjmcc.2009.10.022_bib89 article-title: Characterization of 5,6- and 8,9-epoxyeicosatrienoic acids (5,6- and 8,9-EET) as potent in vivo angiogenic lipids publication-title: J. Biol. Chem. doi: 10.1074/jbc.M501730200 – volume: 32 start-page: 367 year: 2004 ident: 10.1016/j.yjmcc.2009.10.022_bib130 article-title: Transcriptional suppression of cytochrome P450 genes by endogenous and exogenous chemicals publication-title: Drug Metab. Dispos. doi: 10.1124/dmd.32.4.367 – volume: 82 start-page: 19 year: 2007 ident: 10.1016/j.yjmcc.2009.10.022_bib99 article-title: Emerging mechanisms for growth and protection of the vasculature by cytochrome P450-derived products of arachidonic acid and other eicosanoids publication-title: Prostaglandins Other Lipid Mediat. doi: 10.1016/j.prostaglandins.2006.05.025 – volume: 11 start-page: 597 year: 2001 ident: 10.1016/j.yjmcc.2009.10.022_bib134 article-title: Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid publication-title: Pharmacogenetics doi: 10.1097/00008571-200110000-00006 – volume: 281 start-page: 905 year: 2006 ident: 10.1016/j.yjmcc.2009.10.022_bib91 article-title: Fibroblast growth factor-2 is a downstream mediator of phosphatidylinositol 3-kinase-Akt signaling in 14,15-epoxyeicosatrienoic acid-induced angiogenesis publication-title: J. Biol. Chem. doi: 10.1074/jbc.M503945200 – volume: 39 start-page: 690 year: 2002 ident: 10.1016/j.yjmcc.2009.10.022_bib17 article-title: Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension publication-title: Hypertension doi: 10.1161/hy0202.103788 – volume: 102 start-page: 9772 year: 2005 ident: 10.1016/j.yjmcc.2009.10.022_bib22 article-title: Soluble epoxide hydrolase is a therapeutic target for acute inflammation publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.0503279102 – volume: 24 start-page: 401 year: 1996 ident: 10.1016/j.yjmcc.2009.10.022_bib114 article-title: Endotoxemia in rats is associated with induction of the P4504A subfamily and suppression of several other forms of cytochrome P450 publication-title: Drug. Metab. Dispos. doi: 10.1016/S0090-9556(25)07366-0 – volume: 314 start-page: 260 year: 2005 ident: 10.1016/j.yjmcc.2009.10.022_bib42 article-title: Activation of peroxisome proliferator-activated receptor alpha by substituted urea-derived soluble epoxide hydrolase inhibitors publication-title: J. Pharmacol. Exp. Ther. doi: 10.1124/jpet.105.085605 – volume: 284 start-page: C422 year: 2003 ident: 10.1016/j.yjmcc.2009.10.022_bib104 article-title: TNF-alpha -induced endothelial cell adhesion molecule expression is cytochrome P-450 monooxygenase dependent publication-title: Am. J. Physiol. Cell. Physiol. doi: 10.1152/ajpcell.00271.2002 – volume: 67 start-page: 6665 year: 2007 ident: 10.1016/j.yjmcc.2009.10.022_bib94 article-title: Cytochrome p450 epoxygenase promotes human cancer metastasis publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-06-3643 – volume: 277 start-page: 35105 year: 2002 ident: 10.1016/j.yjmcc.2009.10.022_bib41 article-title: The CYP4A isoforms hydroxylate epoxyeicosatrienoic acids to form high affinity peroxisome proliferator-activated receptor ligands publication-title: J. Biol. Chem. doi: 10.1074/jbc.M201575200 – volume: 102 start-page: 2186 year: 2005 ident: 10.1016/j.yjmcc.2009.10.022_bib35 article-title: Attenuation of tobacco smoke-induced lung inflammation by treatment with a soluble epoxide hydrolase inhibitor publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.0409591102 – volume: 285 start-page: L1099 year: 2003 ident: 10.1016/j.yjmcc.2009.10.022_bib117 article-title: Pulmonary cytochrome P-450 2J4 is reduced in a rat model of acute Pseudomonas pneumonia publication-title: Am. J. Physiol. Lung Cell Mol. Physiol. doi: 10.1152/ajplung.00039.2003 – volume: 297 start-page: F740 year: 2009 ident: 10.1016/j.yjmcc.2009.10.022_bib16 article-title: Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension publication-title: Am. J. Physiol. Renal. Physiol. doi: 10.1152/ajprenal.00098.2009 – volume: 109 start-page: 178 year: 2004 ident: 10.1016/j.yjmcc.2009.10.022_bib106 article-title: Inhibition of cytochrome P450 2C9 improves endothelium-dependent, nitric oxide-mediated vasodilatation in patients with coronary artery disease publication-title: Circulation doi: 10.1161/01.CIR.0000105763.51286.7F – volume: 21 start-page: 308 year: 2005 ident: 10.1016/j.yjmcc.2009.10.022_bib127 article-title: Tobacco smoke dysregulates endothelial vasoregulatory transcripts in vivo publication-title: Physiol. Genomics doi: 10.1152/physiolgenomics.00310.2004 – volume: 277 start-page: 34176 year: 2002 ident: 10.1016/j.yjmcc.2009.10.022_bib40 article-title: Constitutive activation of peroxisome proliferator-activated receptor-gamma suppresses pro-inflammatory adhesion molecules in human vascular endothelial cells publication-title: J. Biol. Chem. doi: 10.1074/jbc.M203436200 – volume: 167 start-page: 137 year: 1990 ident: 10.1016/j.yjmcc.2009.10.022_bib26 article-title: 14, 15-Epoxyeicosatrienoic acid promotes endothelial cell dependent adhesion of human monocytic tumor U937 cells publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/0006-291X(90)91741-A – volume: 295 start-page: C1292 year: 2008 ident: 10.1016/j.yjmcc.2009.10.022_bib93 article-title: Epoxyeicosatrienoic acids are part of the VEGF-activated signaling cascade leading to angiogenesis publication-title: Am. J. Physiol. Cell. Physiol. doi: 10.1152/ajpcell.00230.2008 – volume: 25 start-page: 321 year: 2005 ident: 10.1016/j.yjmcc.2009.10.022_bib64 article-title: Cytochrome P4502C9-derived epoxyeicosatrienoic acids induce the expression of cyclooxygenase-2 in endothelial cells publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/01.ATV.0000151648.58516.eb – volume: 14 start-page: 2829 year: 2005 ident: 10.1016/j.yjmcc.2009.10.022_bib139 article-title: The soluble epoxide hydrolase gene harbors sequence variation associated with susceptibility to and protection from incident ischemic stroke publication-title: Hum. Mol. Genet. doi: 10.1093/hmg/ddi315 – volume: 276 start-page: 36059 year: 2001 ident: 10.1016/j.yjmcc.2009.10.022_bib4 article-title: Epoxygenase pathways of arachidonic acid metabolism publication-title: J. Biol. Chem. doi: 10.1074/jbc.R100030200 – volume: 103 start-page: 18733 year: 2006 ident: 10.1016/j.yjmcc.2009.10.022_bib34 article-title: Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.0609158103 – volume: 17 start-page: 349 year: 2007 ident: 10.1016/j.yjmcc.2009.10.022_bib136 article-title: CYP2J2 and CYP2C8 polymorphisms and coronary heart disease risk: the Atherosclerosis Risk in Communities (ARIC) study publication-title: Pharmacogenet. Genomics doi: 10.1097/FPC.0b013e32809913ea – volume: 26 start-page: 1215 year: 2006 ident: 10.1016/j.yjmcc.2009.10.022_bib14 article-title: Endothelium-derived hyperpolarizing factor: where are we now? publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/01.ATV.0000217611.81085.c5 – volume: 243 start-page: 388 year: 1989 ident: 10.1016/j.yjmcc.2009.10.022_bib48 article-title: Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats publication-title: Science doi: 10.1126/science.2492116 – volume: 314 start-page: 522 year: 2005 ident: 10.1016/j.yjmcc.2009.10.022_bib90 article-title: Arachidonic acid epoxygenase metabolites stimulate endothelial cell growth and angiogenesis via mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways publication-title: J. Pharmacol. Exp. Ther. doi: 10.1124/jpet.105.083477 – volume: 291 start-page: H1999 year: 2006 ident: 10.1016/j.yjmcc.2009.10.022_bib49 article-title: Rat mesenteric arterial dilator response to 11,12-epoxyeicosatrienoic acid is mediated by activating heme oxygenase publication-title: Am. J. Physiol. Heart Circ. Physiol. doi: 10.1152/ajpheart.00082.2006 – volume: 40 start-page: 273 year: 2002 ident: 10.1016/j.yjmcc.2009.10.022_bib123 article-title: P450-dependent arachidonic acid metabolism and angiotensin II-induced renal damage publication-title: Hypertension doi: 10.1161/01.HYP.0000029240.44253.5E – volume: 90 start-page: 1020 year: 2002 ident: 10.1016/j.yjmcc.2009.10.022_bib101 article-title: Inhibition of vascular smooth muscle cell migration by cytochrome p450 epoxygenase-derived eicosanoids publication-title: Circ. Res. doi: 10.1161/01.RES.0000017727.35930.33 – volume: 195 start-page: 199 year: 2007 ident: 10.1016/j.yjmcc.2009.10.022_bib133 article-title: Synergistic effect of cytochrome P450 epoxygenase CYP2J2⁎7 polymorphism with smoking on the onset of premature myocardial infarction publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2006.11.001 – volume: 268 start-page: 12260 year: 1993 ident: 10.1016/j.yjmcc.2009.10.022_bib63 article-title: Renal vasodilator activity of 5,6-epoxyeicosatrienoic acid depends upon conversion by cyclooxygenase and release of prostaglandins publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(18)31383-8 – volume: 40 start-page: 529 year: 2008 ident: 10.1016/j.yjmcc.2009.10.022_bib19 article-title: Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease publication-title: Nat. Genet. doi: 10.1038/ng.129 – volume: 17 start-page: 770 year: 2003 ident: 10.1016/j.yjmcc.2009.10.022_bib87 article-title: Cytochrome P450 2C9-derived epoxyeicosatrienoic acids induce angiogenesis via cross-talk with the epidermal growth factor receptor (EGFR) publication-title: FASEB J. doi: 10.1096/fj.02-0640fje – volume: 101 start-page: 235 year: 2000 ident: 10.1016/j.yjmcc.2009.10.022_bib39 article-title: Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators publication-title: Circulation doi: 10.1161/01.CIR.101.3.235 – volume: 52 start-page: 447 year: 2004 ident: 10.1016/j.yjmcc.2009.10.022_bib9 article-title: Distribution of soluble epoxide hydrolase and of cytochrome P450 2C8, 2C9, and 2J2 in human tissues publication-title: J. Histochem. Cytochem. doi: 10.1177/002215540405200403 – volume: 88 start-page: 44 year: 2001 ident: 10.1016/j.yjmcc.2009.10.022_bib27 article-title: Endothelium-derived hyperpolarizing factor synthase (cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries publication-title: Circ. Res. doi: 10.1161/01.RES.88.1.44 – volume: 46 start-page: 67 year: 2009 ident: 10.1016/j.yjmcc.2009.10.022_bib74 article-title: Epoxyeicosatrienoic acid prevents postischemic electrocardiogram abnormalities in an isolated heart model publication-title: J. Mol. Cell. Cardiol. doi: 10.1016/j.yjmcc.2008.09.711 – volume: 35 start-page: 1126 year: 2007 ident: 10.1016/j.yjmcc.2009.10.022_bib44 article-title: Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha publication-title: Drug. Metab. Dispos. doi: 10.1124/dmd.106.013839 – volume: 285 start-page: F955 year: 2003 ident: 10.1016/j.yjmcc.2009.10.022_bib119 article-title: Role of epoxyeicosatrienoic acids in renal functional response to inhibition of NO production in the rat publication-title: Am. J. Physiol. Renal. Physiol. doi: 10.1152/ajprenal.00092.2003 – volume: 290 start-page: H491 year: 2006 ident: 10.1016/j.yjmcc.2009.10.022_bib10 article-title: Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BK(Ca) channels: implications for soluble epoxide hydrolase inhibition publication-title: Am. J. Physiol. Heart Circ. Physiol. doi: 10.1152/ajpheart.00927.2005 – volume: 87 start-page: 992 year: 2000 ident: 10.1016/j.yjmcc.2009.10.022_bib18 article-title: Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids publication-title: Circ. Res. doi: 10.1161/01.RES.87.11.992 – volume: 442 start-page: 511 year: 2001 ident: 10.1016/j.yjmcc.2009.10.022_bib83 article-title: The coronary endothelium-derived hyperpolarizing factor (EDHF) stimulates multiple signalling pathways and proliferation in vascular cells publication-title: Pflugers. Arch. doi: 10.1007/s004240100565 – volume: 277 start-page: 15671 year: 2002 ident: 10.1016/j.yjmcc.2009.10.022_bib84 article-title: Cytochrome P450 2C9-induced endothelial cell proliferation involves induction of mitogen-activated protein (MAP) kinase phosphatase-1, inhibition of the c-Jun N-terminal kinase, and up-regulation of cyclin D1 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M110806200 – volume: 291 start-page: H537 year: 2006 ident: 10.1016/j.yjmcc.2009.10.022_bib77 article-title: Epoxyeicosatrienoic acids in cardioprotection: ischemic versus reperfusion injury publication-title: Am. J. Physiol. Heart Circ. Physiol. doi: 10.1152/ajpheart.00071.2006 – volume: 41 start-page: 709 year: 2003 ident: 10.1016/j.yjmcc.2009.10.022_bib122 article-title: Decreased renal cytochrome P450 2C enzymes and impaired vasodilation are associated with angiotensin salt-sensitive hypertension publication-title: Hypertension doi: 10.1161/01.HYP.0000047877.36743.FA – volume: 101 start-page: 1321 year: 2004 ident: 10.1016/j.yjmcc.2009.10.022_bib105 article-title: Reduction of ischemia and reperfusion-induced myocardial damage by cytochrome P450 inhibitors publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.0308185100 – volume: 44 start-page: 707 year: 1993 ident: 10.1016/j.yjmcc.2009.10.022_bib113 article-title: Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture publication-title: Mol. Pharmacol. doi: 10.1016/S0026-895X(25)13247-1 – volume: 97 start-page: 263 year: 2007 ident: 10.1016/j.yjmcc.2009.10.022_bib66 article-title: Acute tissue-type plasminogen activator release in human microvascular endothelial cells: the roles of Galphaq, PLC-beta, IP3 and 5,6-epoxyeicosatrienoic acid publication-title: Thromb. Haemost. doi: 10.1160/TH05-02-0092 – volume: 13 start-page: 715 year: 2003 ident: 10.1016/j.yjmcc.2009.10.022_bib135 article-title: Allelic variants of cytochromes P450 2C modify the risk for acute myocardial infarction publication-title: Pharmacogenetics doi: 10.1097/00008571-200312000-00002 – volume: 102 start-page: 16747 year: 2005 ident: 10.1016/j.yjmcc.2009.10.022_bib29 article-title: The antiinflammatory effect of laminar flow: the role of PPARgamma, epoxyeicosatrienoic acids, and soluble epoxide hydrolase publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.0508081102 – volume: 290 start-page: 1250 year: 1999 ident: 10.1016/j.yjmcc.2009.10.022_bib115 article-title: Modulation of cytochrome P-450 gene expression in endotoxemic mice is tissue specific and peroxisome proliferator-activated receptor-alpha dependent publication-title: J. Pharmacol. Exp. Ther. doi: 10.1016/S0022-3565(24)35029-3 – volume: 100 start-page: 1703 year: 2007 ident: 10.1016/j.yjmcc.2009.10.022_bib46 article-title: Heme oxygenase-1 expression in macrophages plays a beneficial role in atherosclerosis publication-title: Circ. Res. doi: 10.1161/CIRCRESAHA.107.151720 – volume: 276 start-page: 14867 year: 2001 ident: 10.1016/j.yjmcc.2009.10.022_bib7 article-title: Pathways of epoxyeicosatrienoic acid metabolism in endothelial cells. Implications for the vascular effects of soluble epoxide hydrolase inhibition publication-title: J. Biol. Chem. doi: 10.1074/jbc.M011761200 – volume: 290 start-page: H55 year: 2006 ident: 10.1016/j.yjmcc.2009.10.022_bib43 article-title: 14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-alpha publication-title: Am. J. Physiol. Heart Circ. Physiol. doi: 10.1152/ajpheart.00427.2005 – year: 2009 ident: 10.1016/j.yjmcc.2009.10.022_bib79 article-title: Beneficial effects of soluble epoxide hydrolase inhibitors in myocardial infarction model: insight gained using metabolomic approaches publication-title: J. Mol. Cell. Cardiol. doi: 10.1016/j.yjmcc.2009.08.017 – volume: 118 start-page: 5489 year: 2005 ident: 10.1016/j.yjmcc.2009.10.022_bib88 article-title: Cytochrome P450 epoxygenases 2C8 and 2C9 are implicated in hypoxia-induced endothelial cell migration and angiogenesis publication-title: J. Cell. Sci. doi: 10.1242/jcs.02674 – volume: 39 start-page: 2073 year: 2008 ident: 10.1016/j.yjmcc.2009.10.022_bib82 article-title: Soluble epoxide hydrolase gene deletion is protective against experimental cerebral ischemia publication-title: Stroke doi: 10.1161/STROKEAHA.107.508325 – volume: 285 start-page: 1276 year: 1999 ident: 10.1016/j.yjmcc.2009.10.022_bib11 article-title: Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids publication-title: Science doi: 10.1126/science.285.5431.1276 – volume: 47 start-page: 557 year: 2006 ident: 10.1016/j.yjmcc.2009.10.022_bib121 article-title: Tumor necrosis factor alpha blockade increases renal Cyp2c23 expression and slows the progression of renal damage in salt-sensitive hypertension publication-title: Hypertension doi: 10.1161/01.HYP.0000198545.01860.90 – volume: 329 start-page: 1275 year: 2005 ident: 10.1016/j.yjmcc.2009.10.022_bib110 article-title: Eicosapentaenoic acid metabolism by cytochrome P450 enzymes of the CYP2C subfamily publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2005.02.103 – volume: 303 start-page: 768 year: 2002 ident: 10.1016/j.yjmcc.2009.10.022_bib111 article-title: Cytochrome p-450 epoxygenase metabolites of docosahexaenoate potently dilate coronary arterioles by activating large-conductance calcium-activated potassium channels publication-title: J. Pharmacol. Exp. Ther. doi: 10.1124/jpet.303.2.768 – volume: 228 start-page: 786 year: 2003 ident: 10.1016/j.yjmcc.2009.10.022_bib57 article-title: 11,12-Epoxyeicosatrienoic acid attenuates synthesis of prostaglandin E2 in rat monocytes stimulated with lipopolysaccharide publication-title: Exp. Biol. Med. (Maywood) doi: 10.1177/15353702-0322807-03 – volume: 25 start-page: 904 year: 2005 ident: 10.1016/j.yjmcc.2009.10.022_bib32 article-title: Nuclear factor kappaB signaling in atherogenesis publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/01.ATV.0000160340.72641.87 – volume: 60 start-page: 310 year: 2001 ident: 10.1016/j.yjmcc.2009.10.022_bib70 article-title: Overexpression of cytochrome P450 CYP2J2 protects against hypoxia-reoxygenation injury in cultured bovine aortic endothelial cells publication-title: Mol. Pharmacol. doi: 10.1124/mol.60.2.310 – volume: 82 start-page: 155 year: 2007 ident: 10.1016/j.yjmcc.2009.10.022_bib50 article-title: 11,12-Epoxyeicosatrienoic acid stimulates heme-oxygenase-1 in endothelial cells publication-title: Prostaglandins Other Lipid Mediat. doi: 10.1016/j.prostaglandins.2006.07.001 – volume: 401 start-page: 493 year: 1999 ident: 10.1016/j.yjmcc.2009.10.022_bib13 article-title: Cytochrome P450 2C is an EDHF synthase in coronary arteries publication-title: Nature doi: 10.1038/46816 – volume: 110 start-page: 1128 year: 2004 ident: 10.1016/j.yjmcc.2009.10.022_bib45 article-title: Laminar flow activates peroxisome proliferator-activated receptor-gamma in vascular endothelial cells publication-title: Circulation doi: 10.1161/01.CIR.0000139850.08365.EC – volume: 39 start-page: 609 year: 2002 ident: 10.1016/j.yjmcc.2009.10.022_bib112 article-title: Cytochrome P450-dependent eicosapentaenoic acid metabolites are novel BK channel activators publication-title: Hypertension doi: 10.1161/hy0202.103293 – volume: 36 start-page: 205 year: 2008 ident: 10.1016/j.yjmcc.2009.10.022_bib129 article-title: Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer publication-title: Drug Metab. Dispos. doi: 10.1124/dmd.107.018747 – volume: 46 start-page: 978 year: 2009 ident: 10.1016/j.yjmcc.2009.10.022_bib72 article-title: Protective actions of epoxyeicosatrienoic acid: dual targeting of cardiovascular PI3K and KATP channels publication-title: J. Mol. Cell. Cardiol. doi: 10.1016/j.yjmcc.2009.01.009 – volume: 46 start-page: 842 year: 2005 ident: 10.1016/j.yjmcc.2009.10.022_bib81 article-title: An epoxide hydrolase inhibitor, 12-(3-adamantan-1-yl-ureido)dodecanoic acid (AUDA), reduces ischemic cerebral infarct size in stroke-prone spontaneously hypertensive rats publication-title: J. Cardiovasc. Pharmacol. doi: 10.1097/01.fjc.0000189600.74157.6d – volume: 3 start-page: 562 year: 1997 ident: 10.1016/j.yjmcc.2009.10.022_bib108 article-title: Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase publication-title: Nat. Med. doi: 10.1038/nm0597-562 – volume: 45 start-page: 120 year: 2006 ident: 10.1016/j.yjmcc.2009.10.022_bib36 article-title: From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions publication-title: Prog. Lipid. Res. doi: 10.1016/j.plipres.2005.12.002 – volume: 99 start-page: 2222 year: 2002 ident: 10.1016/j.yjmcc.2009.10.022_bib100 article-title: Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.261710799 – volume: 302 start-page: 406 year: 2003 ident: 10.1016/j.yjmcc.2009.10.022_bib37 article-title: Medicine. PPARs as therapeutic targets: reverse cardiology publication-title: Science doi: 10.1126/science.1091172 – volume: 29 start-page: 1265 year: 2009 ident: 10.1016/j.yjmcc.2009.10.022_bib103 article-title: Inhibition of soluble epoxide hydrolase attenuated atherosclerosis, abdominal aortic aneurysm formation, and dyslipidemia publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/ATVBAHA.109.186064 – volume: 64 start-page: 482 year: 2003 ident: 10.1016/j.yjmcc.2009.10.022_bib137 article-title: Polymorphisms in human soluble epoxide hydrolase publication-title: Mol. Pharmacol. doi: 10.1124/mol.64.2.482 – volume: 96 start-page: 2676 year: 1995 ident: 10.1016/j.yjmcc.2009.10.022_bib47 article-title: Endothelial cell expression of vasoconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide publication-title: J. Clin. Invest. doi: 10.1172/JCI118334 – volume: 99 start-page: 442 year: 2006 ident: 10.1016/j.yjmcc.2009.10.022_bib24 article-title: Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function publication-title: Circ. Res. doi: 10.1161/01.RES.0000237390.92932.37 – volume: 295 start-page: H2128 year: 2008 ident: 10.1016/j.yjmcc.2009.10.022_bib76 article-title: Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia–reperfusion injury in vivo publication-title: Am. J. Physiol. Heart Circ. Physiol. doi: 10.1152/ajpheart.00428.2008 – volume: 293 start-page: H142 year: 2007 ident: 10.1016/j.yjmcc.2009.10.022_bib97 article-title: Cytochrome P-450 epoxygenases protect endothelial cells from apoptosis induced by tumor necrosis factor-alpha via MAPK and PI3K/Akt signaling pathways publication-title: Am. J. Physiol. Heart Circ. Physiol. doi: 10.1152/ajpheart.00783.2006 – volume: 78 start-page: 415 year: 1996 ident: 10.1016/j.yjmcc.2009.10.022_bib12 article-title: Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors publication-title: Circ. Res. doi: 10.1161/01.RES.78.3.415 – volume: 38 start-page: 192 year: 2008 ident: 10.1016/j.yjmcc.2009.10.022_bib33 article-title: EET displays anti-inflammatory effects in TNF-alpha stimulated human bronchi: putative role of CPI-17 publication-title: Am. J. Respir. Cell. Mol. Biol. doi: 10.1165/rcmb.2007-0232OC – volume: 276 start-page: 15983 year: 2001 ident: 10.1016/j.yjmcc.2009.10.022_bib65 article-title: Activation of Galphas mediates induction of tissue-type plasminogen activator gene transcription by epoxyeicosatrienoic acids publication-title: J. Biol. Chem. doi: 10.1074/jbc.M100439200 – volume: 83 start-page: 362 year: 2009 ident: 10.1016/j.yjmcc.2009.10.022_bib80 article-title: Role of B-type natriuretic peptide in epoxyeicosatrienoic acid-mediated improved post-ischaemic recovery of heart contractile function publication-title: Cardiovasc. Res. doi: 10.1093/cvr/cvp134 – volume: 52 start-page: 314 year: 2008 ident: 10.1016/j.yjmcc.2009.10.022_bib102 article-title: Soluble epoxide hydrolase inhibitors reduce the development of atherosclerosis in apolipoprotein e-knockout mouse model publication-title: J. Cardiovasc. Pharmacol. doi: 10.1097/FJC.0b013e318185fa3c – volume: 46 start-page: 867 year: 2009 ident: 10.1016/j.yjmcc.2009.10.022_bib75 article-title: Epoxyeicosatrienoic acids limit damage to mitochondrial function following stress in cardiac cells publication-title: J. Mol. Cell. Cardiol. doi: 10.1016/j.yjmcc.2009.02.028 – volume: 103 start-page: 13646 year: 2006 ident: 10.1016/j.yjmcc.2009.10.022_bib60 article-title: Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitors publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.0605908103 – volume: 300 start-page: 115 year: 1993 ident: 10.1016/j.yjmcc.2009.10.022_bib52 article-title: Inhibition of cytochromes P450 by nitric oxide and a nitric oxide-releasing agent publication-title: Arch. Biochem. Biophys. doi: 10.1006/abbi.1993.1016 – volume: 93 start-page: 148 year: 2008 ident: 10.1016/j.yjmcc.2009.10.022_bib38 article-title: Epoxygenases and peroxisome proliferator-activated receptors in mammalian vascular biology publication-title: Exp. Physiol. doi: 10.1113/expphysiol.2007.038612 – volume: 82 start-page: 131 year: 2002 ident: 10.1016/j.yjmcc.2009.10.022_bib3 article-title: P-450 metabolites of arachidonic acid in the control of cardiovascular function publication-title: Physiol. Rev. doi: 10.1152/physrev.00021.2001 – volume: 15 start-page: 1640 year: 2006 ident: 10.1016/j.yjmcc.2009.10.022_bib107 article-title: Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study publication-title: Hum. Mol. Genet. doi: 10.1093/hmg/ddl085 – volume: 109 start-page: 335 year: 2004 ident: 10.1016/j.yjmcc.2009.10.022_bib138 article-title: Polymorphism of the soluble epoxide hydrolase is associated with coronary artery calcification in African–American subjects: the Coronary Artery Risk Development in Young Adults (CARDIA) study publication-title: Circulation doi: 10.1161/01.CIR.0000109487.46725.02 – volume: 282 start-page: 2891 year: 2007 ident: 10.1016/j.yjmcc.2009.10.022_bib23 article-title: Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted mice publication-title: J. Biol. Chem. doi: 10.1074/jbc.M608057200 – volume: 43 start-page: 55 year: 2004 ident: 10.1016/j.yjmcc.2009.10.022_bib8 article-title: Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function publication-title: Prog. Lipid Res. doi: 10.1016/S0163-7827(03)00049-3 – volume: 42 start-page: 687 year: 2007 ident: 10.1016/j.yjmcc.2009.10.022_bib78 article-title: Mechanisms by which epoxyeicosatrienoic acids (EETs) elicit cardioprotection in rat hearts publication-title: J. Mol. Cell. Cardiol. doi: 10.1016/j.yjmcc.2006.11.020 – volume: 111 start-page: 5581 year: 2008 ident: 10.1016/j.yjmcc.2009.10.022_bib95 article-title: An essential role for SRC-activated STAT-3 in 14,15-EET-induced VEGF expression and angiogenesis publication-title: Blood doi: 10.1182/blood-2007-11-126680 – volume: 9 start-page: 3339 year: 2004 ident: 10.1016/j.yjmcc.2009.10.022_bib58 article-title: Non-prostaglandin eicosanoids in fever and anapyrexia publication-title: Front. Biosci. doi: 10.2741/1486 – volume: 275 start-page: H2113 year: 1998 ident: 10.1016/j.yjmcc.2009.10.022_bib59 article-title: 14,15-Epoxyeicosatrienoic acid inhibits prostaglandin E2 production in vascular smooth muscle cells publication-title: Am. J. Physiol. |
| SSID | ssj0009433 |
| Score | 2.385496 |
| SecondaryResourceType | review_article |
| Snippet | The cytochrome P450 (CYP) epoxygenase enzymes CYP2J and CYP2C catalyze the epoxidation of arachidonic acid to epoxyeicosatrienoic acids (EETs), which are... Abstract The cytochrome P450 (CYP) epoxygenase enzymes CYP2J and CYP2C catalyze the epoxidation of arachidonic acid to epoxyeicosatrienoic acids (EETs), which... |
| SourceID | pubmedcentral proquest pubmed crossref elsevier |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 331 |
| SubjectTerms | Cardiovascular Cardiovascular Diseases - enzymology Cardiovascular Diseases - genetics Cardiovascular Diseases - pathology Cardiovascular System - enzymology Cardiovascular System - pathology CYP2C CYP2J Cytochrome P-450 CYP2J2 Cytochrome P-450 Enzyme System - metabolism Cytochrome P450 EET Endothelial Epoxide Hydrolases - metabolism Epoxyeicosatrienoic acid Epoxygenase Humans Inflammation Inflammation - enzymology Inflammation - pathology Solubility Soluble epoxide hydrolase |
| Title | Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0022282809004647 https://www.clinicalkey.es/playcontent/1-s2.0-S0022282809004647 https://dx.doi.org/10.1016/j.yjmcc.2009.10.022 https://www.ncbi.nlm.nih.gov/pubmed/19891972 https://www.proquest.com/docview/733841992 https://pubmed.ncbi.nlm.nih.gov/PMC2813356 |
| Volume | 48 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: Elsevier SD Complete Freedom Collection [SCCMFC] customDbUrl: eissn: 1095-8584 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0009433 issn: 0022-2828 databaseCode: ACRLP dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection customDbUrl: eissn: 1095-8584 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0009433 issn: 0022-2828 databaseCode: .~1 dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals [SCFCJ] customDbUrl: eissn: 1095-8584 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0009433 issn: 0022-2828 databaseCode: AIKHN dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVLSH databaseName: Elsevier Journals customDbUrl: mediaType: online eissn: 1095-8584 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0009433 issn: 0022-2828 databaseCode: AKRWK dateStart: 19700301 isFulltext: true providerName: Library Specific Holdings |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swED_aFMZexr6XfRQ97DFebUmW5McSVrKFljFW1jdhyzJJ6JwSp7C87G_fnS2ny7p1sKeA4sOy73T3k_W7O4C3SeydyNM0crGLI0mfrHIEztTNPfFCeK4MJQqfnqnJufx4kV7swbjPhSFaZfD9nU9vvXUYOQpv8-hqPqccX_p6wU2ctedzeh8OMP4YM4CD4w_TydlN7V3ZdZQn4joJ9MWHWprXZvHNua5uJbG8OP9bgLoNQH_nUf4SmE4ewoOAKNlxN-lHsOfrx3DvNJyZP4HFeLNeuhmVJWCfZBozhNzfN2g3GL-aESPbKy59OzovPZttyhVudxs_YnldMsSHbNX1q0cNsmXF3A6DlaGFolF1CZBP4fzk_ZfxJAodFiKX8ngdmSxBx4vzF5Wscp4WwuVa0h5G8SxXlXA-zRHjKY_IqEwqbZTO0UdoU2FUS514BoN6WfsXwLQzypQl1w4hWlFWptAqllrhfszwIlND4P1rtS6UH6cuGJe255ktbKsLaoyZ0SDqYgijrdBVV33j7stlry_bJ5aiK7QYHe4W038S801Yzo1NbMNtbG-Z3BDUVnLHav99S9abk8X1TIc0ee2X143VQhhJnOAhPO-s6-bJM9RXpmm-O3a3vYBKhe_-U89nbclwbhIhUvXyf-f7Cu53tAni8byGwXp17d8gGlsXh7D_7kdyGNYc_U4_f53-BDnxNm0 |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKkYAL4s1SHj5w3NDE7xzRqtUC3YpDK_VmOY6j3VXJVputxF747czEyZZtS5G4OrbiZMYzn-1vZgj5mKXBcydl4lOfJgKPrBwAZ6zmngXOA1MGA4Unx2p8Kr6eybMdMupjYZBW2dn-aNNba9217Hd_c_9iNsMYXzy9YCbN2_s5fY_cF5Jp3IF9-nXF88hFrCePtHXs3qceakle6_kP72PWSuR4MfY393QTfl5nUf7hlg6fkMcdnqSf45Sfkp1QPyMPJt2N-XMyH61XCz_FpAT0u5ApBcD9cw1aA96rGVLUvOI8tK2zMtDpulzCZrcJQ-rqkgI6pMtYrR7kRxcV9Vv8VQr6CSoVwx9fkNPDg5PROOnqKyResnSVmDwDswvz55WoHJMF904L3MEoljtVcR-kA4SnAuCiMqu0UdqBhdCmAp8mPX9JdutFHV4Tqr1RpiyZ9gDQirIyhVap0Ap2Y4YVuRoQ1v9W67vk41gD49z2LLO5bWWBZTFzbARZDMhwM-gi5t64u7vo5WX7sFIwhBZ8w93D9G3DQtMt5sZmtmE2tTcUbkDUZuSWzv77lbRXJwurGa9oXB0Wl43VnBuBjOABeRW16-rLc5BXrnG-W3q36YCJwref1LNpmzCcmYxzqd7873w_kIfjk8mRPfpy_G2PPIoECmT0vCW7q-VleAe4bFW8b9fdbyvANZI |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cytochrome+P450+epoxygenases%2C+soluble+epoxide+hydrolase%2C+and+the+regulation+of+cardiovascular+inflammation&rft.jtitle=Journal+of+molecular+and+cellular+cardiology&rft.au=Deng%2C+Yangmei&rft.au=Theken%2C+Katherine+N&rft.au=Lee%2C+Craig+R&rft.date=2010-02-01&rft.eissn=1095-8584&rft.volume=48&rft.issue=2&rft.spage=331&rft_id=info:doi/10.1016%2Fj.yjmcc.2009.10.022&rft_id=info%3Apmid%2F19891972&rft.externalDocID=19891972 |
| thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00222828%2FS0022282809X00155%2Fcov150h.gif |